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RNA-protein complexes play essential regulatory roles at nearly all levels of gene expression.
Using in vivo crosslinking and RNA capture, we report a comprehensive RNA-protein inter-
actome in a metazoan at four levels of resolution: single amino acids, domains, proteins and
multisubunit complexes. We devise CAPRI, a method to map RNA-binding domains (RBDs)
by simultaneous identiﬁcation of RNA interacting crosslinked peptides and peptides adjacent
to such crosslinked sites. CAPRI identiﬁes more than 3000 RNA proximal peptides in
Drosophila and human proteins with more than 45% of them forming new interaction
interfaces. The comparison of orthologous proteins enables the identiﬁcation of evolutionary
conserved RBDs in globular domains and intrinsically disordered regions (IDRs). By com-
paring the sequences of IDRs through evolution, we classify them based on the type of
motif, accumulation of tandem repeats, conservation of amino acid composition and high
sequence divergence.
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RNA–protein complexes are key components in the lifecycle of RNA1,2. RNA–protein interactions can be studiedon a high-throughput level from two angles3. The protein-
centric angle relies on isolating proteins and sequencing the
RNAs bound to them4–7. On the other hand, the RNA-centric
approach detects proteins bound to RNA using mass
spectrometry8,9. An example of an RNA-centric method is ﬁxing
RNA–protein interactions in vivo using UV irradiation and iso-
lating polyA-containing (polyA+) RNAs using oligodT-coupled
beads and highly stringent washes10–12. This approach was
used to identify around 1800 mammalian direct RNA-binding
proteins (RBPs), including hundreds of novel RBPs, many of
which are involved in non-canonical pathways like energy
metabolism and DNA repair2,13–16. However, proteins which
interact with polyA+ RNA indirectly have not been probed on
a systematic level until now.
Most of the new RBPs discovered by the RNA-centric RBP
capture methods do not possess known RNA-binding domains
(RBDs). Previous RBD mapping approaches have applied mass
spectrometric techniques to identify peptides covalently bound
to RNA17. The throughput of these techniques is limited due
to the heterogeneity in peptide-ribonucleotide conjugates and
difﬁculty of identifying the conjugated peptide tandem MS
spectra by standard database search engines. Even with a
specialised database search algorithm and homogeneous thio-
uridine-mediated UV crosslinking, the polyA+ RNA interactome
capture method could only identify 133 unique crosslinking
sites in 57 S. cerevisiae proteins18,19. Alternative approaches rely
on predicting crosslinked peptides by detecting peptides
adjacent to the site of crosslink20,21 or by comparing peptide
intensities between crosslinked and non-crosslinked samples22.
Here, we introduce CAPRI (Crosslinked and Adjacent
Peptides-based RNA-binding domain Identiﬁcation), a technique
which enhances RBD discovery by simultaneously identifying
both crosslinked peptides (in the immediate vicinity of the
RNA–protein interface) and adjacent peptides (next to the
crosslinked peptide) from the same sample. We apply CAPRI
to Drosophila and human cells, uncovering 234 new Pfam
RBDs in the two species. We identify 29 conserved RBDs with
a globular structure. Furthermore, we uncover hundreds of
IDRs mapped by 870 CAPRI-peptides. Based on manual
screening, we ﬁnd 40 pairs of IDRs whose RNA-binding function
and location is conserved between Drosophila and human
orthologs. We also produce exhaustive coverage of the Drosophila
RNA-binding proteome (RBPome). Our study compares the
RBPs captured by formaldehyde (FA) and ultraviolet (UV)
crosslinking at a high-throughput level, and shows that FA
crosslinking can retrieve not only direct RNA binders but
also the secondary layer of RNA-interacting proteins. Our inte-
gration of RBD discovery by CAPRI with FA- and UV-mediated
interactome capture provides the basis for a more complete
understanding of the metazoan RNA–protein interaction
network.
Results
The Drosophila RBPome at four levels of resolution. Our study
presents comprehensive coverage of the Drosophila RBPome at
four levels of resolution (refer to Fig. 1 for the workﬂows used in
the study). We ﬁrst identiﬁed the RNA–protein complexes in the
cell by combining formaldehyde crosslinking and polyA+ pull-
down (Fig. 1a, (1)). Next, we scored direct RBPs using UV
crosslinking (Fig. 1a, (2)). Following this, we identify RBDs
through a combination of adjacent and crosslinked peptides using
a methodology we developed: CAPRI. The CAPRI technique
provided the ﬁnal two levels of resolution of our study. Owing to
its use of UV crosslinking and a parallel workﬂow, the CAPRI
pipeline mapped both the peptides in proximity to RNA (Fig. 1b,
(3)) and the precise amino acids contacting RNA (Fig. 1b, (4)).
In a separate analysis, we also applied FA crosslinking to
RBD capture (Fig. 1c) and showed it to be a viable com-
plementary method to the CAPRI workﬂow. We additionally
applied CAPRI interactome capture to human cells in order to
analyse the evolutionary conservation of newly identiﬁed
RBDs between the two species. These interactome capture tech-
niques and the datasets acquired using them are discussed in
detail in the following sections.
UV- and FA-mediated capture of direct and indirect RBPs.
Although Drosophila melanogaster constitutes an important
metazoan model organism, RBPome description in Drosophila
(~800 proteins) is limited compared to mammals (~1800 pro-
teins)2. Previous attempts to characterise the ﬂy RBPome have
relied exclusively on UV crosslinking14,23, which only retrieves
proteins in direct contact with RNA nucleobases11,12,18,24. In
contrast, FA can create inter-protein and RNA–protein cross-
links, which are ideal for capturing both direct and indirect
RNA–protein interactions (Supplementary Note 1)8,25. Therefore,
we adapted the polyA+ interactome capture to use FA cross-
linking in addition to UV crosslinking in Drosophila Schneider
(S2) cells. We optimised the FA interactome capture such that
comparable amounts of both proteins and RNA were captured
by FA and UV crosslinking (Fig. 2a and Supplementary Fig. 1a, b,
c). The speciﬁcity of interactome capture was validated (Supple-
mentary Fig. 1b–h) by silver staining (Fig. 2a) and western blot
against the known Drosophila RBPs Mle, Glorund, Squid and
Rump, with histone H3 and actin serving as negative controls
(Fig. 2b).
We performed the UV- and FA-based interactome captures in
three biological replicates. We observed high consistency between
the replicates as assessed by RNA proﬁles (Supplementary
Fig. 1d, e), exclusion of genomic DNA (Supplementary Fig. 1d,
f), recovery of mRNA (Supplementary Fig. 1g) and protein
analysis (silver staining; Supplementary Fig. 1h). Next, the
samples were subjected to GeLC-MS analysis26. We used label-
free quantiﬁcation and a moderated t-test to select proteins
enriched in the crosslinked samples at a false discovery rate of 1%
and further applied a ﬁlter for eightfold increase compared to the
non-crosslinked control samples. This led to the determination of
two Drosophila RNA-interacting protein datasets: the UV-
crosslinked RNA-binding proteome (UV-RBPome) comprising
1512 proteins and the FA-crosslinked RNA-binding proteome
(FA-RBPome) encompassing 2327 proteins (Fig. 2d, Supplemen-
tary Fig. 2a–f and Supplementary Data 1).
The Drosophila RBPomes obtained using FA and UV cross-
linking showed signiﬁcant overlap both with each other and
with previously published studies. As anticipated, >85% of the
proteins in the UV-RBPome were also represented in the FA-
RBPome (Supplementary Fig. 2c, d). Furthermore, the protein
intensities detected in both UV- and FA-RBPomes were found
to be highly correlated (Pearson correlation > 0.8) (Fig. 2c). We
successfully captured >70% of previously published UV-based
Drosophila embryo RBPomes14,23 (Fig. 2d). It is important to
note that both previous studies were performed on early
embryonic stages (0–2 h14,23 and 4.5–5.5 h14, whereas the S2
cells employed in our work were originally isolated from late
embryonic stages 20–24 h27. We observed > 50% overlap between
our interactomes and predicted ﬂy orthologs of RBPs described
in published RNA interactomes from several species2 (Fig. 2d).
Our UV- and FA-RBPomes together revealed 1021 candidate
RNA-associated proteins (Fig. 2d).
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Fig. 1 Characterisation of RNA–protein complexes, RBPs and RBDs. We characterised the Drosophila RBPome at four levels of resolution. a (green box) On
the ﬁrst two levels of resolution we focus on comprehensive identiﬁcation of RBPs and RNA-associated protein complexes in Drosophila cells. First we used
FA crosslinking to compile a dataset containing both direct and indirect RNA binders (FA-RBPome (1)). At the next level we used UV crosslinking to
generate a dataset composed of direct RNA binders (UV-RBPome (2)). Both FA- and UV-RBPome datasets exhibit peptide coverage across the entire
length of RBPs, which is illustrated by the green FP-peptides in the schematic in the lower panel. b (blue box) The next two levels of resolution focused on
discovery of RNA–protein contact sites. We devised a new approach, termed CAPRI, which integrates two analysis pipelines to facilitate large-scale
identiﬁcation of RBDs. Brieﬂy, UV-crosslinked RBPs are isolated using oligo-dT beads and digested with endoprotease Lys-C to release non-crosslinked
peptides. The RNA-peptide moieties are eluted from the beads, transferred to a 30 kD ﬁlter and washed with 8M urea to remove nonspeciﬁc background
peptides. The crosslinked peptides are further digested with trypsin (cutting C-terminal to K/R) to release the adjacent peptides (coloured blue) as
ﬂowthrough. The RNA-peptide conjugates (orange-red) retained on the ﬁlter were released after degrading the RNA using a cocktail of nucleases. The MS/
MS data from all crosslinked replicates are submitted to PEAKS for a combined search with custom deﬁned monoisotopic masses of RNA adducts to
identify XL-peptides. The non-heterconjugate peptides from all MS/MS data are analysed by MaxQuant. The statistically enriched peptides in the UV
irradiated samples (adjacent-peptides) are reconstructed in silico to the original endoproteinase Lys-C-digested full peptide sequence (ADJ-peptides:
blue). The ADJ-RBPome (3) and XL-RBPome (4) together give the CAPRI-RBPome. c (orange box) The FA-dom-RBPome provides complementary data on
RBDs using FA as a crosslinker. Brieﬂy, 0.1% formaldehyde-crosslinked RBPs are captured using oligo-dT beads and are further digested using Lys-C and
trypsin. Following elution the RNA-peptide crosslinks are reversed by heating and later the nucleic acids are degraded by nucleases. The peptides are
cleaned-up using SP3 puriﬁcation and analysed using LC/MS
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Despite their overall similarity, the FA-RBPome revealed
interesting differences compared to the UV-RBPome, particularly
with respect to the classes of proteins represented. Gene ontology
(GO) enrichment analysis of molecular functions and biological
processes uncovered that the most enriched terms were related
to RNA functions for both RBPomes (Supplementary Fig. 3a, b).
Similarly, KEGG pathway enrichment analysis revealed pathways
like mRNA transport, RNA surveillance and ribosome biogenesis
in both UV- and FA-RBPomes (Fig. 2e and Supplementary
Fig. 3c, d, e). However, the overall coverage of RNA-related
proteins was higher in the FA-RBPome compared to UV-
RBPome. Additionally, novel pathways like endocytosis, valine,
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leucine, isoleucine degradation and DNA replication were more
enriched in the FA-RBPome (Fig. 2e and Supplementary Fig. 4a,
b). Although some of the metabolic enzymes are also present
in the UV-RBPome, as seen previously28, their number is
signiﬁcantly higher in the FA-RBPome (Supplementary Fig. 4c,
d). Thus, we predict that interaction of metabolic proteins with
the mRNA machinery occurs either via indirect binding to bona
ﬁde RBPs or through direct interactions that cannot be recovered
by UV crosslinking.
We next asked whether the RBPs we identiﬁed carried known
RBDs. As expected, classical RBDs like RRM, KH and Helicase
domains were enriched in both UV- and FA-RBPomes (Fig. 2g
and Supplementary Fig. 4e). We also found high enrichment for
InterPro domains such as P-loop containing nucleoside tripho-
sphate hydrolase, WD40 and Armadillo. However, >60% of the
identiﬁed Drosophila proteins in both UV- and FA-RBPomes did
not harbour any of the classical RBDs (see Methods and Fig. 2f).
Thus, it seems likely that these proteins possess new classes of
RBDs that have not yet been catalogued29,30.
CAPRI as a workﬂow for comprehensive identiﬁcation of
RBDs. We were interested in discovering RBDs in the hundreds
of RBPs identiﬁed in our RBPomes. The current standard
methodology employed for RBD mapping is detection of UV-
crosslinked RNA-peptide heteroconjugates by mass spectro-
metry18. Although this analysis delivers single amino acid reso-
lution, the high sample heterogeneity observed with UV-
crosslinked peptides severely hampers its coverage and through-
put (Supplementary Note 2). We overcame these limitations by
isolating peptides adjacent (N- or C-terminal) to the peptides
carrying the crosslinked amino acid. These adjacent peptides
have better abundance and homogeneity compared to
crosslinked peptides (Supplementary Fig. 5a). Furthermore, they
can then be analysed using standard proteomics pipelines. The
RBDmap method used the same principle to successfully identify
adjacent peptides in humans20. However, no methodology until
now has combined analysis of both crosslinked and adjacent
peptides from the same samples. Keeping this in mind, we
developed a new workﬂow: (simultaneous) Crosslinked and
Adjacent Peptide-based RNA-binding domain Identiﬁcation
(CAPRI).
The ﬁrst step of the CAPRI workﬂow involves isolation of bona
ﬁde RBPs from UV-irradiated cells on beads (Fig. 1b). This is
followed by the digestion of bound proteins using Lys-C (cleaves
C-terminal to K) to release any peptides not covalently attached
to RNA (Fig. 3a and Supplementary Fig. 5b–d). After several
washes, the RNA-peptide conjugates were eluted. We devised a
new strategy (RNA-FASP) for enrichment of crosslinked peptides
under stringent conditions (8 M urea) based on the retention
of RNA on 30 kD MWCO centrifugal ﬁlters (FASP ﬁlters)31
(Supplementary Fig. 5e, f). The RNA-peptide conjugates retained
on the ﬁlter were further digested with Lys-C to ensure complete
digestion. The released peptides were collected as a ﬂowthrough
to estimate the proportion of Lys-C missed cleavage sites
(Supplementary Fig. 5h). The peptides remaining on the ﬁlter
were subsequently digested with trypsin (cleaves C-terminal to
K and R) to release the peptides adjacent to the crosslink. The
crosslinked RNA-peptide heteroconjugates were then collected
after digesting the RNA completely (Fig. 1b and Supplementary
Fig. 5g).
The CAPRI analysis approach is bipartite. The ﬁrst branch
detects peptides adjacent to crosslink sites and is thereby capable
of detecting a higher number of RBDs (Fig. 1b, ADJ-RBPome).
The second branch delivers an extremely high-conﬁdence but
smaller set of direct crosslinked peptides (Fig. 1b, XL-RBPome).
The peptides were analysed by two different software pipelines,
one for adjacent peptides and another for crosslinked peptides
(described in the following sections), and then combined together
to identify RBDs at two levels of resolution: peptide and amino
acid level.
CAPRI adjacent peptide analysis. In the ﬁrst branch of the
CAPRI workﬂow, the adjacent peptides were analysed by con-
ventional label-free quantiﬁcation using the MaxQuant
software32,33. A total of 2388 adjacent peptides were obtained
after stringent statistical evaluation (Fig. 3b and Supplementary
Data 2). The selected tryptic adjacent peptides were extended in
silico to the nearest Lys-C digestion sites to encompass the
neighbouring crosslink site (Fig. 1b, See Supplementary Note 3).
Multiple adjacent peptides arising from the same Lys-C-cleaved
peptide were then merged together to give a ﬁnal dataset of 1510
extended RNA-adjacent peptides (termed ADJ-peptides) map-
ping to 574 proteins (termed ADJ-RBPome) in Drosophila
(Supplementary Data 2).
At the outset, the ADJ-RBPome was highly enriched in RNA-
associated GO molecular functions and biological processes
(Fig. 3c and Supplementary Fig. 6b). The ADJ-peptides were
validated as mapping to RBDs by checking for the enrichment of
classical RBDs relative to background peptides identiﬁed from
full proteins (FP-peptides; Fig. 3d, e). Using the ﬂy protein Larp
as an example, we demonstrate the identiﬁcation of RNA-
interacting regions based on ADJ-peptides (Supplementary
Fig. 6a). We additionally performed CAPRI ADJ-peptide analysis
on human HEK293 cells (Fig. 3f and Supplementary Fig. 6c–e).
We identiﬁed a total of 1,609 RNA ADJ-peptides in 543 human
proteins (Supplementary Data 3). Similar to our ﬁndings in
Drosophila, the human proteins were highly enriched for RNA-
related functions and RBDs (Supplementary Fig. 6f–h). Thus,
by using the ADJ-peptide analysis branch of the CAPRI
workﬂow, we recapitulated canonical RBDs in both Drosophila
and human cells.
Fig. 2 RNA interactome capture in Drosophila melanogaster. a Protein proﬁles from interactome capture visualised on a polyacrylamide gel by silver staining.
Sample loading: Input (lanes 1–2); Interactomes captured from UV control (noUV), UV crosslinked (UV), formaldehyde control (noFA), formaldehyde-
crosslinked (FA), and formaldehyde-crosslinked with RNase treatment (FA-RNase) (lanes 4–8); and ﬁnally BSA (20 ng) (lane 9) were utilised to validate
the interactome capture protocol. b Validation of the interactome capture by western blot of selected proteins. Antibodies against known Drosophila RBPs
(Mle, Glorund, Squid, Rump) were used as positive controls, whereas antibodies against H3 and actin served as negative controls. Source data are provided
Supplementary Fig. 19. c Scatter plot of average intensity values of proteins detected in both the UV-RBPome and FA-RBPome. Pearson correlation (r) of
0.83 was observed between the two sets. d Venn diagram of the UV-RBPome (blue), FA-RBPome (orange), previously reported embryo interactomes14,23
(green) and previously reported UV-RBPomes in all species, including the Drosophila embryo RBPomes (light green)2,14,23. e KEGG pathways enriched
in the FA-RBPome (Benjamini–Hochberg correction 1% FDR). Numbers of proteins from the full proteome, FA-RBPome and UV-RBPome present in
each of the pathways are presented. f Fraction of proteins with known RNA-binding domains (RBDs) in the UV- and FA-RBPomes. g Enriched InterPro
domains in the FA-RBPome (Benjamini–Hochberg correction 1% FDR). Number of proteins with enriched InterPro domains along with proteome count
(Benjamini–Hochberg correction 1% FDR). Representative RBDs (left panel) and domains related to RNA function (right panel) are shown
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Fig. 3 Identiﬁcation of RBDs by CAPRI. a On-bead digestion of proteins with Lys-C was veriﬁed after RNase-A digestion by silver staining. The lanes are as
follows: whole-protein eluates at 0 h and 3 h incubation (lanes 2–5); the released peptides following digestion with Lys-C for 3 h (5% of supernatant) and
peptides eluted from beads (Elu) for non-crosslinked ( - ) and UV crosslinked (+ ) samples (lanes 6 to 9). b Clustered heatmap of raw intensities (log2)
of adjacent peptides detected in the four biological replicates of non-crosslinked and UV-crosslinked samples in Drosophila. Adjacent peptides in UV
crosslinked samples were selected by applying a moderated t-test with a Benjamini–Hochberg correction (FDR 5%) and additional ﬁltering for an eightfold
intensity increase relative to the non-crosslinked samples. Adjacent peptides selected after statistical analysis are depicted in the last lane with maximum
intensity. c GO terms (Molecular function) enriched in the Drosophila ADJ-RBPome. d The fraction of ADJ-peptides mapping to canonical RBDs is plotted
along with the fraction of full-protein peptides (FP-peptides) mapping to the same domains from the UV- and FA-RBPomes. e Domains enriched in
ADJ-peptides compared to FP-peptides from UV- and FA-RBPomes. f Same as b but for three biological replicates in humans
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CAPRI crosslinked peptide analysis. In the second branch of
CAPRI, we analysed crosslinked peptides using a newly developed
pipeline. The CAPRI protocol permits enrichment of crosslinked
peptides over non-crosslinked peptides from the same sample
(Fig. 1b). This makes it possible for crosslinked peptides, present
in lower stoichiometric abundance, to be detected in the data-
dependent acquisition mode of MS. As the masses of conjugated
RNA-peptide molecules are observed as the sum of their indivi-
dual components34, the RNA adducts can be treated as post
translational modiﬁcations (PTMs) by the MS analysis software
(Supplementary Note 4). Since the number of PTMs which need
to be deﬁned for this purpose are in the hundreds, only specia-
lised database search-based strategies have been used in analysing
crosslinked peptides in a high-throughput manner thus far18,19,35.
We designed a workﬂow that not only detects crosslinked pep-
tides by de novo search but also reduces the expert spectrum
annotation work to a minimum by analysing all MS/MS spectra a
priori. The de novo sequencing of the peptide moiety was per-
formed by the PEAKS algorithm36 followed by database identi-
ﬁcation in the PEAKS software37 (see Methods for details).
Brieﬂy, we designed custom RNA-PTMs taking into con-
sideration the fragmentation pathways observed in previously
published data34. The HCD/CID fragmentation of crosslinked
peptides in MS/MS preferentially cleaves the glycosidic and
phosphodiester bonds but not the covalent link between the base
and the amino acid side chain. Thus, we treated the four standard
ribonucleotides (A, G, C, U) as if each was composed of two
PTMs: the ribonucleobase (A’, G’, C’, U’) and the rest of the
ribonucleotide (ribose and phosphate) (Supplementary Data 4
and Supplementary Fig. 7a, b). The position of the base PTM
on the peptide enabled identiﬁcation of the crosslinked amino
acid. Our design made it possible to cover all RNA sequence
combinations of up to 3 nucleotides in only 34 RNA-PTMs.
These reduced numbers of RNA-PTMs could be used in the de
novo step (peptide sequence tag generation) of spectra identiﬁca-
tion (SS3 workﬂow in Supplementary Fig. 7b). The crosslinked
spectra containing non-canonical combinations of nucleotide
fragments were removed in silico (Supplementary Fig. 7c).
Finally, the spectra were manually curated to produce a ﬁnal
set of crosslinked peptides, which we termed XL-peptides
(Fig. 4a). We also manually annotated a few example spectra
with marker ions, neutral losses and RNA-peptide conjugate
(adduct) ions (Supplementary Data 5 and 6).
XL-peptide analysis uncovered hundreds of high-conﬁdence
RBDs in both Drosophila and humans (Supplementary Data 6–9).
We identiﬁed a total of 829 unique XL-peptides mapping to 262
unique peptide sequences in 115 proteins in Drosophila
(Drosophila XL-RBPome) (Fig. 4b). One-hundred seventy-seven
(67.5%) of these Drosophila XL-peptide sites mapped to canonical
RBDs (Fig. 4b). The remaining 85 peptides represent new sites
of RNA interaction. Similarly, a total of 961 unique XL-peptides
were identiﬁed in 280 unique peptide sequences mapping to
135 proteins in the human XL-RBPome. Two-hundred sixteen
(77.14%) of the human XL-peptide sites overlapped with
canonical RBDs. The remaining 64 XL-peptides represented
new sites of RNA interaction (Fig. 4b).
We validated the XL-peptides by visualising their positions
relative to RNA in seven available RNA-protein crystal structures
(Structures and annotated spectra in Supplementary Data 6,
Fig. 4c and Supplementary Fig. 7d-f). All mapped XL-peptides
were located close to RNA in 3D space. Of the 17 amino acid
crosslink sites that we mapped in these structures (Fig. 4c and
Supplementary Data 6), 15 were in close proximity to RNA. We
show here an annotated spectrum of a peptide from HNRNPC
(Fig. 4c) crosslinked to AU RNA with a covalent bond between
valine/phenylalanine and uridine (Fig. 4c inset). In another
example, an XL-peptide maps to the helix-turn-helix DNA
binding domain (a non-classical RBD) in PA2G4 (Fig. 4d). The
peptide is very close to a positively charged surface of the
protein (Fig. 4d inset). Thus, XL-peptides identify both classical
and novel RNA-interacting surfaces.
In-depth analysis of all XL-peptides revealed a clear preference
for particular amino acids and nucleotides at the sites of
crosslinks. We could identify the site of crosslink at single amino
acid resolution in half of the XL-peptides. These amino acids had
higher fractions of aromatic, hydrophobic and aliphatic residues
compared to amino acids observed in close proximity to RNA
in previously published RNA protein structures38. The F, Y and
C residues are especially enriched at the sites of crosslinks in our
data (Fig. 4e). Similarly, the nucleotide composition of the RNA
sequences crosslinked to the peptides showed a clear bias for
the uridine base (Fig. 4f), consistent with previous reports18.
We also observed a new class of crosslinked peptides where only
the base was present in the crosslinked RNA-peptide hetero-
conjugate (Supplementary Fig. 7g, h and Supplementary Data 5
Spectra 14,15). Such a crosslink could only be detected if the
glycosidic bond between the nucleobase and ribose sugar is
cleaved either during sample preparation or subsequent to
ionisation as an MS in-source decay product.
XL-peptides overlap with identiﬁed ADJ-peptides. As we have
simultaneously isolated ADJ- and XL-peptides from the same
samples we expected a high degree of complementarity between
XL-peptides with ADJ-peptides. We found that >60% of the XL-
peptides overlapped with ADJ-peptides (Fig. 5b). Furthermore,
when extended by the mid-range of tryptic peptide length
(30 amino acids) on either side, >90% of XL-peptides overlapped
with ADJ-peptides. XL-peptides and ADJ-peptides are therefore
positionally complementary. In one example, the ADJ-peptides
and XL-peptides mapping to one of the RRM domains in Dro-
sophila pUf68 and its human ortholog PUF60 show clear com-
plementarity (Fig. 5a). This strongly supports the reliability of
using ADJ-peptides for RBD identiﬁcation and gives us increasing
conﬁdence in those sites, which exhibit only ADJ-peptides (with
no concomitant XL-peptide). We combined XL-peptides and
ADJ-peptides into a single dataset, which we termed CAPRI-
peptides.
Classes of identiﬁed RNA interacting regions. Using CAPRI
we identiﬁed classical RBDs like RRM and KH-domains along
with non-classical RBDs like R3H, Pumilio repeat, CSD, C2H2,
FYVE-related and CCCH domains (Fig. 5a and Supplementary
Fig. 9a–e). CAPRI analyses also discovered hundreds of pre-
viously uncharacterised RBDs in Drosophila and human cells
(Supplementary Data 10). We identiﬁed and classiﬁed novel
domains by clustering information on the overlap of the CAPRI-
peptides with Pfam domains39 and IDRs (Fig. 5c). We considered
all peptides not overlapping with RNA-binding Pfam domains
(see Methods) to be mapping to new RBDs and sub-categorised
them into novel RBD Pfam domains, IDRs and unan-
notated structured domains (Fig. 5d). The XL-peptides were also
seen to map across all domain subclasses (Fig. 5c). Some exam-
ples of high-conﬁdence XL-peptides with annotated spectra
mapping to new RBDs are shown in Supplementary Data 7.
Compared to other workﬂows, CAPRI supports maximum
stringency for removal of non-speciﬁc RNA–peptide interactions
and allows simultaneous identiﬁcation of crosslinked and
adjacent peptides. A comparison of CAPRI and existing
methods20,22,40 is outlined in Supplementary Fig. 8a. We found
that the fraction of CAPRI-peptides mapping to known RBDs
are similar to those observed in other recent publications
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Fig. 4 Identiﬁcation of UV crosslinked XL-peptides using PEAKS PTM analysis. a Peptides detected in Drosophila (left) and human (right) PEAKS analysis:
canonical non-crosslinked peptides (blue), ﬁltered crosslinked peptides (red) and true XL-peptides (green). b Summary of all XL-peptides detected in
Drosophila (left) and human (right). The crosslinks bar depicts the number of distinct RNA-peptide heteroconjugates. The peptides bar depicts the number
of distinct peptide sequences. The proteins bar depicts the number of distinct proteins that are deﬁned by the aforementioned peptides. c An example of an
annotated XL-peptide spectrum from HNRNPC with a dinucleotide (AU) covalently attached to peptide VFIGNLNTLVVK. The y ions series (blue) and
b ion series (red) were automatically annotated by PEAKS. The manually added RNA marker ions (A+ , cUMP+ , cAMP+ ) and RNA-peptide conjugates
(peptide-AU) are shown in green and in magenta, respectively. Inset: The XL-peptide mapped to amino acids 18–28 in HNRNPC structure (PDB ID 2MXY).
The protein is shown in blue, the RNA in green and the XL-peptide in red. Amino acids Phe and Val are shown in ball and stick models. The stacking
interaction between Phe and proximal uridine base is pointed out (arrowhead). d Annotated spectrum of an XL-peptide peptide from PA2G4. The m/z
ratios identiﬁed by PEAKS search are shown in red. The marker ion (C’) is shown in green. The peaks containing heteroconjugates with neutral losses are
shown in purple. The nucleotide structures are shown for the purpose of visualising adducts present on the peptides and they may not represent the actual
structure of the heteroconjugate. Inset: Position of the XL-peptide (green) in the crystal structure of the protein (PDB ID 2Q8K). The coulombic
electrostatic potential of the protein surface is shown in blue for positive and red for negatively charged surfaces. e Composition analysis of amino acids
identiﬁed as sites of crosslinks in Drosophila (green) and human (pink) compared to the composition of amino acids involved in direct interaction with
RNA in known 3D structures (grey)38. f Bar chart displaying the distribution of ribonucleotide adducts observed in Drosophila XL-peptides
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performed in mouse and human cells (Supplementary Fig. 8b).
Additionally, a large proportion of the Pfam domains discovered
by CAPRI-peptides in human cells were also identiﬁed in other
mammalian RBD captures (Supplementary Fig. 8c).
FA-based RBD identiﬁcation. FA has previously been used to
identify RNA-interacting surfaces of single proteins41. However,
its suitability for mapping RBDs at a high-throughput scale has
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performed on-bead proteolysis of oligo-dT-immobilised FA-
crosslinked RBPs with Lys-C and trypsin (Fig. 1c). The RNA was
eluted and RNA-peptide bonds were de-crosslinked by heat, after
which the RNA was degraded. The peptides were further digested
with trypsin and analysed by mass spectrometry (Supplementary
Fig. 10b, see Methods for details). From three biological replicates
a total of 554 peptides (FA-dom-peptides) mapping to 162 pro-
teins (FA-dom-RBPome) were identiﬁed in Drosophila (see
Methods and Supplementary Data 11, Supplementary Fig. 10c).
These proteins were also enriched for classical RBPs (Supple-
mentary Fig. 10d) and overlapped signiﬁcantly with other Dro-
sophila RBPomes (Supplementary Fig. 10e, f). Two-hundred
twenty-ﬁve (40.6%) of the 554 FA-dom-peptides mapped to
classical RBDs (Fig. 3d). The majority (57.4%) of FA-dom-
peptides overlapped with ADJ-peptides and about a third (36.9%)
of the XL-peptides overlapped with the FA-dom-peptides. Some
examples of these overlaps can be seen in the peptide coverages
shown in Supplementary Figs 6a and 9c–e. As a proof of prin-
ciple, these overlaps clearly suggest that FA-dom-peptides can
also be used to map RBDs. However, as the number of peptides
uncovered by CAPRI was higher than in the FA-dom-peptides,
we opted to focus on CAPRI-peptides for all subsequent analyses.
Organisation of protein complexes based on proximity to
RNA. We found signiﬁcant overlaps between the whole protein
and CAPRI interactomes (Fig. 5e and Supplementary Fig. 11a).
Our four datasets: FA-, UV-, ADJ- and XL-RBPomes in Droso-
phila deﬁne sets of proteins with increasing conﬁdence for direct
RNA interaction and with increasing precision in identifying
the site of interaction. We hypothesised that this understanding
could be used to produce a new way of visualising RNA-binding
protein complex hierarchies based on the putative proximity of
each protein component to RNA (see Methods). We imple-
mented a visualisation based on concentric circles to show the
predicted proximities of individual components of the 79-subunit
spliceosomal complex to RNA (colour-coded in Fig. 5f). Spli-
ceosome component Sf3b1 was placed in the innermost circle in
our visualisation as it was recognised by a CAPRI XL-peptide in
its N-terminus (Fig. 5f, darkest red and Supplementary Data 7
spectrum 26). Sf3b1 is known to be responsible for recognition
of the splice site branch-point during RNA splicing42–44. In
addition, several ADJ-peptides mapped to the Armadillo HEAT
repeat region of both ﬂy Sf3b1 (Fig. 5f, lower panel) and its
human ortholog SF3B1 (Fig. 5g). The same region has previously
been shown to be close to RNA by cryo-EM42,43 (Fig. 5g).
We also applied this principle to visualise hierarchies in other
complexes like the CCR4-NOT complex, which is involved in the
deadenylation of mRNA (Supplementary Fig. 11b). The HEAT
repeat-containing and Tristetraprolin binding domains within the
Not1 protein bind RNA (Supplementary Fig. 11c). In humans,
the CNOT1 protein forms a scaffold on which the rest of the
complex members assemble45 and in yeast the Not1 C-terminal
domain binds poly(U) RNA in vitro together with Not2 and Not5
(Not3 in Drosophila)46. We mapped the RNA-binding region of
the ﬂy Rga/NOT2 protein to its N-terminus, thus placing it in the
innermost circle of our visualisation (Supplementary Fig. 11c).
A similar analysis of large complexes like cytoplasmic ribosome
and mitochondrial 55S ribosome along with smaller complexes
such as TREX complex also revealed organisation of the proteins
involved in RNA interaction (Supplementary Fig. 11d–f). Extend-
ing similar analysis to complexes or pathways without known
RNA-related functions will permit us to gain insights into which
of their components directly interact with RNA. For example,
we identify RNA-associated proteins involved in oxidative
phosphorylation (Supplementary Fig. 12a). We could also map
the RNA interaction sites in ﬂy ATPsyngamma, which is an
extramembranous subunit (F1) of mitochondrial membrane ATP
synthase (Supplementary Fig. 12b and Supplementary Data 7
Spectrum 1). We also identiﬁed the RNA bound peptides of ﬂy
mt:ND1 and COX1 proteins (Supplementary Fig. 12c, d). Thus,
the combined analysis of CAPRI interactomes and RNA–protein
interactomes provides insight into RNA-proximity-based protein
complex hierarchy.
Validation of newly identiﬁed RBPs. We validated a selection of
proteins representing diverse functional classes using two sepa-
rate techniques in human cells. First, we independently developed
a technique, which captures all large RNA ( > 200 nucleotides) in
the cell by adapting commercially available silica solid phase
extraction (similar to the recently published 2C technique47).
Brieﬂy, UV-crosslinked cells were resuspended in highly dena-
turing guanidine thiocyanate-containing buffer (Supplementary
Fig. 13a, see Methods for details). After passing the solution
through a genomic DNA elimination column, the RBPs were
isolated on an RNA-binding column. Following stringent washes
the RBPs were eluted from the column. These were validated by
silver staining (Supplementary Fig. 13b, c) and western blots
against positive controls (classical RBPs: ADAR, DHX9,
HNRNPM1, HUR3A2, POLRMT; non-classical RBP: GAPDH)
and histone H3 as a negative control (Supplementary Fig. 13d).
We observed that several proteins involved in oxidative phos-
phorylation (OXPHOS Complex V member ATP51A and
Complex II member SDHA), DNA repair (MSH6 and XRCC5)
Fig. 5 Classiﬁcation of CAPRI-peptides. a Visualisation of adjacent, ADJ- and XL-peptides detected in ﬂy pUf68 and its human ortholog PUF60. The
visualisation tracks from top to bottom for each protein: full-protein peptide (FP-peptide) (green), signiﬁcant adjacent peptides (blue), extended adjacent
peptides: ADJ-peptides (blue), XL-peptides (red), K and R amino acid tracks, disordered regions extracted from MobiDb (grey) along with labelled globular
domains (blue boxes). b Summary of all XL-peptides overlapping with ADJ-peptides with (red) or without extending (light red) the XL-peptides by
30 amino acids in silico. c Clustered heat maps representing the distribution of XL- and ADJ-peptides identiﬁed in Drosophila (left) and humans (right)
overlapping with Pfam, RBD Pfam and IDR. Left of each panel: XL-peptides and different classes of RBDs. d Distribution of CAPRI-peptides in RBD Pfam,
novel Pfam, and novel structured domains as well as novel IDRs. e Overlap of Drosophila proteins identiﬁed in the UV-, ADJ- and XL-RBPomes. f Display of
layered interactome representation for spliceosomal complex members after aggregating information from full-protein and domain interactome captures in
Drosophila. The proteins are arranged in concentric circles where the conﬁdence in and resolution of the site of RNA interaction increases with proximity
to the RNA node (white) shown in the centre. The layers going from outside to inside: not-detected (grey), FA-RBPome (green), UV-RBPome (light red),
ADJ-RBPome (red) and XL-RBPome (dark red). As an example of a novel surface interacting with RNA, Sf3b1 protein domain peptide coverage is shown
below (N-term XL-peptide). g Identiﬁcation of RNA-binding regions in human SF3B1. Top: The ADJ-peptides (blue) and Castello et al.21 RBDpep peptides
(cyan) mapped onto available sequence in the human SF3B1 protein structure (pale orange) (PDB ID 6AHD). Additional proteins in the structure are
removed for better visualisation. The RNA is shown in pale green in stick model. Bottom: Peptide coverages of the ortholog human SF3B1. The visualisation
tracks are as in a, except for the addition of tracks for Castello et al.21 RBDpep extended peptides (cyan) and Mullari et al.40 pCLAP extended
peptides (blue)
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2,15 and mitochondrial tRNA/protein import (TOMM20) bind
RNA (Supplementary Fig. 13e). Some of these proteins had
been predicted (but not veriﬁed) to interact with RNA in pre-
viously published interactome capture experiments2.
Second, we utilised PNK assays as an orthogonal approach2,48
(see Methods). We ﬁrst validated the assay using three known
RBPs: SRRT, PPIE and RACK1 (Fig. 6a). Next, we applied the
assay to SAP18, a splicing protein49, which until now has not
been conﬁrmed to directly bind RNA (Fig. 6a). Third, we
conﬁrmed two proteins involved in cellular signalling as new
RBPs, namely PEBP1/RKIP and CSNKD1. PEBP1 is a well-
established tumour suppressor protein involved in a multitude of
signalling pathways such as Raf/MEK/ERK, NFkB, PI3K/Akt/
mTOR and Wnt50. The radioactive smear above PEBP1 is speciﬁc
to radiolabelled RNA as it is sensitive to high amounts of RNase
treatment (Fig. 6b). CSNKD1 represents another protein engaged
in regulation of multiple pathways, including Wnt signalling,
DNA repair and circadian rhythms51. We additionally validated
the cytoskeletal ERM family proteins ezrin (EZR), radixin (RDX)
and moesin (MSN), which had been predicted to interact with
RNA in previous RBPomes2,21 (Fig. 6c).
We were also able to verify RNA binding of three metabolic
enzymes using PNK assay. Two of them, ALDH6A1 and MCAT,
are newly identiﬁed RBPs with RNA-binding regions deﬁned by
our ADJ-RBPomes (and also predicted in previous RBPomes2)
(Fig. 6d). ALDH6A1 plays a role in both the valine, leucine,
isoleucine degradation (Supplementary Fig. 4b), while MCAT
is involved in mitochondrial fatty acid beta oxidation. The
short/branched chain acyl-CoA dehydrogenase CG3902 was
predicted to bind RNA based on our FA-RBPome analyses. It is
a member of both the fatty acid and valine, leucine, isoleucine
degradation pathways (Supplementary Fig. 4b). We cloned its
human ortholog ACADSB and validated its ability to directly
bind RNA using the PNK assay (Fig. 6d). This ﬁnding
demonstrates that the use of FA crosslinking can extend the
discovery potential of comprehensive RNA interactome capture.
Evolutionary conservation of globular RBDs. We uncovered
RBDs in 328 ortholog pairsin Drosophila and humans using
CAPRI (Fig. 7a). The majority of the proteins which contained
novel domains in Drosophila also contained novel domains in
their human orthologs (Supplementary Fig. 14a and Supple-
mentary Data 12). We also observed a considerable overlap in the
Pfam domains recovered in both species (Fig. 7b). We identiﬁed
29 novel conserved Pfam RBDs and a further 46 novel InterPro
RBDs (Fig. 7c, d). We classiﬁed the domains into metabolic
enzymes, domains involved in the post translational modiﬁcation
of proteins and other structural domains. Over 60% of the novel
Pfam RBDs from Drosophila were also identiﬁed in other mam-
malian studies21,22,40,52 (Fig. 7e and Supplementary Fig. 14e and
Data 13). We consider a few interesting examples of conserved
RBDs below.
CAPRI successfully discovered additional conserved novel
domains in proteins already known to carry a classical RBD.
One such example is the human protein LARP1, in which CAPRI-
peptides identiﬁed both a classical RBD (La-RRM) and the non-
classical RBD DM15 (Fig. 8a top panel). CAPRI also mapped these
same domains in the Drosophila ortholog larp (Fig. 8a bottom
panel) and human paralog LARP1B (Supplementary Fig. 14b). We
veriﬁed the RNA-binding activity of the human DM15 repeat by
PNK assay (Fig. 8e). In support of our result, the DM15 repeat was
recently independently shown to bind the mRNA cap53. We
observed CAPRI-peptides identifying additional disordered
regions (RG- and SR-rich regions preceding the La-RRM domain)
in both ﬂies and humans (Fig. 8a and Supplementary Fig. 14b).
We also independently validated several other conserved globular
RBDs: SPRY54 and P-loop-containing nucleoside triphosphate
hydrolase domains in HNRNPU (Fig. 8b, e) and its ﬂy ortholog
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Fig. 6 Validation of RBPs using PNK assay. Brieﬂy, 3Flag-HBH-tagged
proteins are stably expressed in Flp-In T-Rex 293 cells. The proteins are
afﬁnity puriﬁed from UV crosslinked and non-crosslinked cells under
denaturing conditions. RNA bound to proteins is labelled with radioactive
32P using the PNK enzyme. The RNA–protein heteroconjugates are
separated by size (SDS-PAGE) and transferred to a membrane on which
the RNA binding capacity is detected by autoradiography (RNA band
labelled with red asterisk). The proteins are detected by western blot
(bottom) using anti-Flag antibody (protein band labelled with green
asterisk). The assay was performed on the following class of proteins:
a RNA-related proteins comprising the classical RRM domain-containing
RBPs serrate RNA effector molecule (SRRT) and peptidylprolyl isomerase E
(PPIE), as well as WD40 domain-containing protein receptor for activated
C kinase 1 (RACK1) and splicing related protein Sin3A-associated protein 18
(SAP18). b Cell signalling proteins phosphatidylethanolamine binding
protein 1 (PEBP1) and casein kinase 1 delta (CSNK1D). For PEBP1 an
additional control with high amounts of RNase I treatment (100 units) is
included alongside the standard (1 unit) treatment employed in all
experiments. c Cytoskeleton ERM family proteins Radixin (RDX), Ezrin
(EZR) and Moesin (MSN). An additional control with high amounts of
RNase I is included for RDX. dMetabolic enzymes aldehyde dehydrogenase
6 family member A1 (ALDH6A1), malonyl-CoA-acyl carrier protein
transacylase (MCAT) and short/branched chain acyl-CoA dehydrogenase
(ACADSB)
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human ILF3, ZFR, STRBP21 and their ﬂy ortholog Zn72D (Fig. 8c,
e and Supplementary Fig. 14d). We further substantiated the
reliability of novel RBD discovery by CAPRI by extrapolating a
GTP-binding domain identiﬁed in Drosophila NON1 protein to
its orthologous protein in humans, GTPBP4, and verifying it with
PNK assay (Fig. 8d, e). We have further summarised interesting
new conserved domains and the proteins harbouring them in
Fig. 8f and Supplementary Fig. 15.
CAPRI uncovers RNA-binding motifs in IDRs. One of the
strengths of the CAPRI methodology is its capacity to identify
RNA-binding sequences in unstructured segments of protein,
which are intractable by classical structural approaches. Indeed,
>30% CAPRI-peptides mapped to IDRs. This is consistent
with previous reports21,22,29,55. CAPRI sequences are rich in
disordered amino acids and triplets of amino acids such as
RGG, RSS, GFG and YGG, which are predicted to be RNA
associated29,55,56 (Supplementary Fig. 16 and Supplementary
Note 6). We found many motifs using the MEME tool57. We
classiﬁed the IDR-based motifs into four categories: charged
arginine-containing motifs, aromatic motifs, single amino acid-
repeat motifs and tandem repeats motifs.
The ﬁrst category of motifs consists of positively charged
RG[G] or RS motifs (Fig. 9a–c). These motifs can occur in
tandem or in combination with other motifs in over a hundred
sites in Drosophila and humans. Regions rich in RG[G]/RS
repeats are positively charged and can bind the negative
backbone of RNA21,29,55,58. We identiﬁed a new RG containing
motif with extended glycine repeats (Fig. 9b). It is important to
note that the number of glycines in classical RG motifs (Fig. 9a)
has been shown to inﬂuence binding to different sequences of
RNAs58. Strikingly, we also found a novel class of motifs with
alternating positively and negatively charged residues (RD/RE
repeats) (Fig. 9c). All the above motifs contain R/S residues,
which can undergo phospho/methyl/dimethyl modiﬁcations
and such modiﬁcations can be used to control RNA binding of
the disordered regions29.
The second category of motifs we uncovered in IDR-based
RBDs exhibit an aromatic amino acid-rich pattern with YG or
NGF repeats (Fig. 9d, e). YG-rich repeats have been shown to
undergo phase transitions and participate in RNA granule
formation in vivo59. For example, we identify XL-peptides
overlapping with the disordered YG-rich C-terminal region
in human HNRNPA1 (Supplementary Data 7; spectra 27, 28).
The spectra suggest a stacking interaction between the aromatic
ring of tyrosine and RNA bases. The YG-rich sequence of
HNRNPA1 also contains an amyloid-forming sequence, muta-
tions in which have been associated with amyotrophic lateral
sclerosis60. The third category of motifs is the tandem repeat
motifs. In one example of such a motif, we found the DDDR
sequence motif repeated 22 times in human EIF3A and once in
its ﬂy ortholog eIF3-S10 (Supplementary Fig. 17a, b). Similar
repeats were observed in other human proteins like RBM12B and
PPP1R10, along with Drosophila proteins like CG5787 (Supple-
mentary Fig. 17c). Thus, use of short tandem repeats of amino
















































































































Fig. 7 Conservation of RBDs between human and Drosophila proteins. a Mapping of proteins identiﬁed by ADJ-peptides in Drosophila (left) and humans
(right) onto DOIPT ortholog pairs (centre). Proteins with no orthologs are noted by the lighter shade of colour in each of the species columns. b Overlap of
all identiﬁed Pfam domains in Drosophila (blue) and humans (yellow). c Overlap of new Pfam domains in orthologous proteins identiﬁed in both species.
d Overlap of new InterPro domains in orthologous proteins identiﬁed in both species. e Clustered heatmap representing all the non-RBD Pfam domains
identiﬁed in Drosophila using the CAPRI protocol together with the identiﬁcation of the same domains in all human (CAPRI, RBDpep[21] and pCLAP[40])
and mouse (RBDpep and RBR-ID[22]) protocols. The domains are manually annotated as belonging to three categories: metabolic enzymes, domains
involved in protein modiﬁcation and the remaining structured domains
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One of the most important ﬁndings in our motif analysis was
the presence of single amino acid-repeat motifs containing
glutamine, alanine or histidine stretches (Fig. 9f–h). Consistent
with this ﬁnding, the polyQ region of whi3 protein has been
shown to be necessary for RNA-mediated granule formation in
yeast61. PolyQ and polyA have also been implicated in protein
aggregate formation in diseases like Huntington’s disease and
oculopharyngeal muscular dystrophy62.
Evolutionary conservation of RNA-binding IDRs. The fre-
quencies of RBD motif usage show species-speciﬁc bias (Fig. 9a–i).
Among the subtypes of R-containing motifs, the G-rich subtype
(Fig. 9b) is more frequently observed in Drosophila, whereas the
RG repeat subtype is more abundant in humans (Fig. 9a). With
regard to aromatic motifs, the NFG-containing motif is more
frequently observed in Drosophila compared to humans (Fig. 9e).
Among the single amino acid-repeat motifs, Drosophila CAPRI-
peptides are richer in polyQ, polyA and polyH relative to humans,
whereas polyP is preferred in humans. This mirrors the fact that
relative to other eukaryotes63, the Drosophila proteome exhibits
higher levels of single amino acid repeats in general and polyQ
repeats in particular64. Indeed, polyQ motifs are identiﬁed only in
Drosophila CAPRI-peptides (Fig. 9g). This differential usage of
various motifs in disordered regions of these organisms could be
relevant for the functions of these proteins.
Comparison of CAPRI-peptides mapping to IDRs strongly
suggests that these regions could exhibit conserved RNA-
binding abilities in spite of signiﬁcant sequence divergence. The
IDRs are not constrained by structure, and hence their
sequences can tolerate higher mutation rates compared to those
of globular domains. The high sequence divergence makes
it difﬁcult to predict functions in silico across species. The
CAPRI workﬂow enabled us to obtain a set of functionally





















































































Role in RNA metabolism. 
Serine/arginine protein kinase specific for the SR (serine/arginine-rich
domain) family of splicing factors. 
 
Isomerisation of proline 
Regulatory subunit of Protein phosphatase 2A (PP2A) is a major 
intracellular protein phosphatase  
Ars2 Acts as a mediator between the cap-binding complex (CBC) and 
RNA-mediated gene silencing (RNAi).
Associated with Alagille Syndrome 1.
Pinin/SDK/MemA protein Transcriptional activator binding to the E-box 1 core sequence, mRNA 
surveillance and transport. 
Associated with Melanoma Metastasis and Premenstrual Tension 
Role in mitochondrial apoptosis, assembly of mitochondrial ribosome.
Associated with Mitochondrial Complex IV Deficiency, Fastkd2-




Domain Drosophila Human 
5-FTHF cyclo-ligase Lost MTHFSD 
Protein kinase domain SRPK SRPK1 
Cyclophilin-type peptidyl-
prolyl cis-trans isomerase 
Cyp1 PPIA 
Protein phosphatase 2A,
regulatory B subunit  
wdb  PPP2R5E 
Ars2 SRRT 
Pnn  PNN 







CG8036 TKT Transketolase EC:2.2.1.1 (TK) catalyzes the reversible transfer of a 
two-carbon ketol unit from xylulose  5-phosphate to an aldose 
receptor. This enzyme, together with transaldolase, provides a link
between the glycolytic and pentose-phosphate pathway 
 
Act as chaperones and protect against heat shock
New domain identified by CAPRI Globular domain
Color keys for globular domain annotation
Known RBD
Fig. 8 Validation of globular domains by PNK assay. a Conservation of non-classical RBDs between Drosophila and humans exempliﬁed by the peptide
coverage of Drosophila Larp protein. The tracks from top to bottom: ADJ-peptides (in blue), XL-peptides (in red), RG and RS rich region in the novel IDR
(green bars), protein domains (classical RBDs in blue boxes, novel globular domains in orange boxes, other globular domains in faint pink boxes) and
MobiDb disordered regions (grey bars) with protein length. b As in a for human RBP HNRNPU. c As in a for human RBP ILF3. d As in a for Non1 Drosophila
protein (ortholog of human GTPBP4). e PNK assay performed to detect RNA-binding activity for the non-classical domains of the human proteins shown in
a–d. Autoradiography (red asterisk) and western blot (green asterisk) using anti-Flag antibody after afﬁnity puriﬁcation of Flag-HBH-tagged domains in UV
crosslinked (+ ) and non-crosslinked ( - ) HEK293 cells. From left to right: DM15 domain from LARP1, SPRY and AAA domains from HNRNPU, DZF domain
from ILF3, and GTP-binding domain with Rossmann fold from GTPBP4. f Table describing a few notable conserved RBDs and their biological importance
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features of conservation of RNA-binding function. We found a
total of 142 ortholog pairs in which an IDR was detected in
both species (Supplementary Fig. 17d). Of these, 40 pairs
exhibited positional conservation of the RNA-interacting
IDRs when manually evaluated. By studying 10 of these pairs
we shed light on speciﬁc features that correlate with conservation
of RNA-binding function in IDRs based on the changes observed
at the sequence level (Fig. 10a). We grouped these features
into ﬁve sets.
In the ﬁrst set, we observed conservation of sequence with
minor changes. We discovered an intrinsically disordered
RG-rich region, which binds RNA in both human UBAP2L and
its Drosophila ortholog Lig (Fig. 10b). On performing multiple
sequence alignment, we note that the RG-rich region was
conserved across a much broader range of species than just
between Drosophila and humans (Supplementary Fig. 18a). We
veriﬁed the RNA-binding capacity of human UBAP2L and its
candidate RBD by PNK assay (Fig. 10c).
The second set contains proteins, which possess one of the
motifs of the R-type (Fig. 9a–c), but with different subtypes used
between species. We observe a tendency for RG-rich sequences to
contain more spacer glycine repeats in Drosophila (Fig. 9b)
compared to their orthologous counterparts in humans (Fig. 9a).
This is exempliﬁed by the C-terminal RG repeats in human
apoptosis inhibitor protein API5 and the corresponding region in
the ﬂy ortholog Aac11 (Supplementary Fig. 18b). Such use of
intervening spacer glycines has been reported to affect RNA
sequence preference58. We found many examples of similar
sequence changes in other protein pairs, which are summarised in
Fig. 10a and illustrated in Supplementary Fig. 18c, d.
Third, we observed an expansion of DDDR repeats (Supple-
mentary Fig. 17a) in EIF3A. There is positional conservation of
the RNA interaction function in the C-terminal region of human
EIF3A and Drosophila eIF3-S10 (Supplementary Fig. 17b).
However, the DDDR repeat motif is repeated 22 times in human
EIF3A and only once in its ﬂy ortholog eIF3-S10. It has been
hypothesised that the expansion of tripeptide repeats in IDRs of
EIF3A orthologs (yeast to humans) represents an emergent
property to enable increasingly diverse RNA interactions in
complex interactomes13.
The fourth set consisted of a single IDR region in the ortholog
pair of YBX1 (human) and Yps (ﬂy). Although we could not
determine any clear motifs or extensive sequence conservation
between the ortholog pair, the CAPRI-identiﬁed IDRs of the two
proteins exhibited conserved amino acid composition (Supple-
mentary Fig. 18e).
The IDRs which did not ﬁt into any of the above
groups formed the ﬁfth set. For some ortholog pairs, we observed
a complete change of IDR sequence in the CAPRI-peptides. For
example, the arginine-rich sequence in YLPM1 contains a RE/
RD/RG-rich stretch followed by a proline-rich motif. The
corresponding region in its ﬂy ortholog ZAP3 is rich in glycines
with YG/GP repeats (Fig. 10d). The human YLPM1 RNA-
interacting region was veriﬁed to bind RNA using the PNK assay
(Fig. 10c, d). Another example of a change in a RG region is the
ortholog pair of PRRC2A (human) and Drosophila nocte
(Fig. 10e). PRRC2A contains closely spaced RG repeats, however
Nocte contains a few dispersed RG sequences in the IDR region
in the middle part of the protein. We veriﬁed the human domain
to bind RNA by PNK assay (Fig. 10c).
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Fig. 9 Motif usage in IDRs of CAPRI-peptides. a–c Illustration of arginine-based motifs discovered by MEME analysis57 in disordered regions of Drosophila
and human ADJ-peptides. E-values displayed on top of each motif are calculated by the MEME tool and number of sites (n) are shown for each of
the motifs. The number of sites observed in each of the species are represented as bars below each motif. The maximum number of sites allowed for
motif construction is 50 (see Methods for details). d–e As in a for aromatic amino acid (Y or F)-based motifs discovered in both Drosophila and humans.
f–i As in a for repetitive single amino acid-based motifs discovered in both Drosophila and humans
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Discussion
In this study, we present a comprehensive analysis of the
Drosophila RNA-protein interactome, identifying 2327 polyA+
RNA-associated proteins (FA-RBPome) and 1512 direct
polyA+ RNA-binding proteins (UV-RBPome). Employing FA
crosslinking enabled us to identify a secondary interaction
layer comprising proteins involved in metabolism, endocytosis
and DNA replication (Fig. 2e and Supplementary Figs 4 and
12). We independently veriﬁed that 14 of these proteins bind
RNA using the orthogonal PNK assay and a newly developed
silica-based assay (Fig. 6 and Supplementary Fig. 13). These
results suggest widespread crosstalk between the post-
transcriptional machinery and other central cellular pathways.
We established a new workﬂow, CAPRI, which enables com-
prehensive and accurate discovery of RBDs in the cell through
simultaneous detection of RNA-protein crosslinked sites and
peptides adjacent to the crosslinks. We successfully employed a
combined de novo and database search using PEAKS software to
identify 1790 unique XL-peptides in Drosophila and human cells.
In addition to XL-peptides, we also mapped 3119 ADJ-peptides in
over a thousand Drosophila and human proteins. The simulta-
neous detection of ADJ-peptides and XL-peptides from the
same sample is a technological advance, which permits CAPRI
to extend its coverage and accuracy. Additionally, PEAKS’ user-
friendly interface and automated internal fragment annotation of
crosslinked spectra, and of single nucleotide crosslinked spectra
in particular, make CAPRI accessible to non-mass spectrometry
experts. In future, the coverage could be extended by using new
combinations of proteases, including Arg-C21, GluC and chy-
motrypsin65. CAPRI could also be easily adjusted to incorporate
elements from recently published adjacent-only workﬂows such
as isotope label-based quantiﬁcation21 and smaller experimental
scale40 to achieve even better results. The ﬁlter-based enrichment
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Fig. 10 Conservation of disordered RNA-binding regions between human and Drosophila proteins. a Table showing examples of different modes of
evolutionary conservation of RNA interacting function in disordered regions of orthologous proteins. b Peptide coverage for the conserved RNA-binding
RG rich region in Lig2 protein (Drosophila) and its ortholog UBAP2L protein (human). Regular expression annotations (RG|GR in red) are restricted to RNA
interacting regions. Globular domains in boxes (globular domains identiﬁed by CAPRI in orange, other globular domains in faint pink). Region cloned
for veriﬁcation is shown by a red bar. c PNK assay performed to detect RNA interaction of disordered regions in human proteins described in b, d, e.
Autoradiography (red asterisk) and western blot (green asterisk) using anti-Flag antibody after afﬁnity puriﬁcation of 3Flag-HBH-tagged disordered regions
in UV crosslinked (+ ) and non-crosslinked ( - ) HEK293 cells. From left to right: Human protein UBAP2L, RG rich regions of UBAP2L, RG-based region of
YLPM1 and R-based PRRC2A. d Peptide coverage in Zap3 protein (Drosophila) and its human ortholog YLPM1 protein. Regular expression annotations
(R, ED, GP, RG|GR) are restricted to RNA interacting regions in Drosophila and to the cloned region in YLPM1 (depicted by a red bar). e Peptide coverage
in nocte (Drosophila) and PRRC2A (human) proteins. Regular expression annotations (RG|GR) are restricted to RNA interacting regions
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other protocols as it allows for highly stringent washes along
with both easy and economical enrichment of crosslinked pep-
tides (Supplementary Fig 8a). CAPRI is also compatible with
recently published methods developed for isolating total RNA
interactomes66–68.
In addition to capturing canonical RBDs, we could also iden-
tify 234 new structured RBDs. Comparing the human and
Drosophila orthologs, we demonstrated the conservation of many
globular domains (Figs. 7c–e and 8 and Supplementary Figs 14
and 15). We also discovered that > 30% of the CAPRI-peptides
map to IDRs. We validated several of these regions individually
using an independent in vivo assay. We not only identiﬁed
classical RNA-associated motifs in IDR regions21 but also found
novel motifs (Fig. 9) with a clear bias for single amino acid motifs
in Drosophila compared to humans. It is likely that these motifs
are responsible for RNA-mediated phase transitions, especially in
combination with other RBDs60,61.
Since IDRs show high sequence divergence and in some cases
accumulation of repeats13 through evolution, it is surprising that
we observe positional conservation of RNA interaction sites
between orthologous IDR pairs13. It will be interesting to see
if the IDR pairs we found would bind to similar or diverse
RNA sequences. It is tempting to speculate that the use of
small motifs and degenerate sequences in RNA-binding IDRs
enables complex organisms to rapidly adapt to their increasingly
diverse transcriptomes69. Application of CAPRI to a more
evolutionarily distant species like S. cerevisiae would permit us
to get an even better insight into the evolution of RNA-binding
disordered regions.
Methods
Formaldehyde crosslinking of S2 cells. Wild-type S2 DRSC cells (Stock #181
from Drosophila Genomics Resource Centre) were grown to exponential phase
(6–8 million cells/ml) in Schneider (S2) medium in shake ﬂasks at 70 rpm at 25 °C.
The cells were crosslinked directly in the medium with 0.1% (v/v) FA (0.05–1% FA
was used for optimisation) at room temperature for 10 min rotating at 8 rpm. The
FA was quenched by adding glycine (ﬁnal concentration 125 mM) and rotating for
5 min at 8 rpm. The cells were pelleted by centrifugation at 600 x g for 5 min. These
cells were resuspended and washed in cold PBS and pelleted again. The cell pellets
were used further or ﬂash frozen in liq. N2 and stored at −80 °C for a maximum
period of 1 month.
UV crosslinking of S2 cells. The cells were counted and plated out on cell culture
dishes at 60% conﬂuency overnight. The next day the medium was removed
and cold PBS is added (4 ml for 15 cm dishes, 10 ml for 25 × 25 cm2 plates). In case
of cells growing in shake ﬂask, cells were pelleted in the medium by spinning at
500 x g for 5 min. For large-scale experiments, 450 × 106 cells were resuspended
in 10 ml ice cold PBS and spread on a 25 × 25 cm2 plate. The plates were placed
immediately on an ice-water mixture, 4 cm away from 254 nm wavelength UV
lamps and irradiated with a total energy of 200 mJ/cm2. The crosslinked cells were
immediately scraped off the plates and pelleted by spinning at 500 x g for 5 min
at 4 °C. After discarding the supernatant the cell pellet was ﬂash frozen in liq. N2
and stored at −80 °C for a maximum of 1 month.
UV crosslinking of HEK293 cells. HEK293 (Flp-In™ T-REx™-293, Thermo Fisher
R78007) cells were grown in 10% FBS in DMEM medium to 90% conﬂuency in 15
cm2 plates. The plates were washed two times with PBS. Finally 4 ml cold PBS was
added and the plates were placed 3 cm away from 254 nm wavelength UV lamps
and irradiated with energy of 200 mJ/cm2. The crosslinked cells were immediately
scraped off the plates and pelleted by spinning at 350 x g for 4 min at 4 °C. After
discarding the supernatant the cell pellet was ﬂash frozen in liq. N2 and stored
at −80 °C for a maximum of 1 month.
Whole-protein RNA interactome capture. UV or FA crosslinked and non-
crosslinked cells were used to isolate polyA+ RNA by oligo-dT magnetic beads
from Drosophila S2 DRSC and HEK293 cells. The proteins covalently crosslinked
to the RNA were isolated, puriﬁed and ultimately analysed by mass spectrometry.
The following protocol was adopted from two previous publications11,12. It has
been streamlined for the particular cell line (Schneider cells, HEK293 cells) by
optimising crosslinking and, homogenisation conditions, cell number to lysis
buffer ratio and washing steps.
Non-crosslinked and crosslinked (UV or FA crosslinked) frozen cell pellets
were resuspended quickly in 10 ml of OLB (Oligo-dT Lysis Buffer − 50 mM
Tris pH 7.5, 10 mM EDTA, 1% lithium dodecyl sulphate (LiDS), 0.5 M LiCl, 5 mM
DTT, 1x cOmplete protease inhibitor from Roche) by using a pipette. The
lysate was immediately homogenised to shear genomic DNA with a rotor stator
homogeniser for 90 s (UV) or 60 s (FA), respectively at 2000 rpm. The extracts
were diluted to 40 ml with OLB. The extract was spun at 10,000 x g for 10 min at
4 °C to pellet aggregates if any. The extract was incubated with a suspension of 4 ml
oligo-dT magnetic beads (NEB) at room temperature for 1 h on a rotating
wheel (set at 10 rpm).
After incubation, the beads were collected on a 50 ml NEB magnetic stand for
25 min at room temperature (RT). The supernatant was removed and ﬂash frozen
or stored on ice for a second round of puriﬁcation. The beads were washed at RT
with 40 ml of OLB for 5 min (10 rpm, rotating wheel). All further wash steps were
carried out at 4 °C. Brieﬂy, the beads were serially washed once with 40 ml WB1
(oligo-dT wash buffer: 20 mM Tris-HCl, pH 7.5, 0.1% LiDS, 500 mM LiCl, 1 mM
EDTA, 5 mM DTT), twice with 40 ml WB2 (oligo-dT wash buffer: 20 mM
Tris-HCl pH 7.5, 0.05% LiDS, 200 mM LiCl, 1 mM EDTA, 5 mM DTT) and ﬁnally
in a smaller 1.5 ml tube twice with 1 ml WB3 (oligo-dT wash buffer: 20 mM
Tris-HCl pH 7.5, 200 mM LiCl, 1 mM EDTA, 5 mM DTT). The RNA was eluted in
400 μl of Elution buffer (20 mM Tris-HCl pH 7.5, 1 mM EDTA) by heating the
mixture in a thermomixer at 56 °C for 4 min followed by removal of magnetic
beads (magnetic stand). The beads were routinely reused for a second round of
RNA isolation from the same cell extract. The RNA concentration and quality
in each eluate were evaluated by employing Qubit assays (DNA-HS, Thermoﬁsher
Q32854; and RNA-BR, Thermoﬁsher Q10210), agarose gel electrophoresis. To
evaluate efﬁciency of mRNA capture equivalent fractions of input and eluted
RNA were ﬁnally puriﬁed (subsequent to complete protein degradation) and
quantiﬁed by quantitative reverse transcription PCR (RT-qPCR). To check for
genomic DNA contamination by qPCR, quantiﬁcation was performed on equal
volumes of reverse transcribed eluate (cDNA) and non-reverse transcribed eluate
(genomic DNA).
Three biological replicates of RBPome protein samples (UV crosslinked, no UV,
FA crosslinked, no FA; 12 samples in total) were subjected to in-gel tryptic
digestion by reconstituting them in 1x LDS sample buffer followed by separation
on 4–12% Bis-Tris gels (NuPAGE) and colloidal Coomassie staining (Instant Blue,
Expedeon). Entire gel lanes were sliced into six pieces and processed (Promega
trypsin) by standard in-gel trypsin digestion70. Finally, tryptic peptide mixtures
were desalted using C18 reversed-phase STAGE tips71.
Selection of RNA retaining ﬁlters for use in CAPRI. The FASP ﬁlters were
selected after screening for total RNA retention. We screened Amicon 30 kD
MWCO and Microcon 30 kD and 10 kD MWCO ﬁlters by adding Drosophila total
RNA on the ﬁlters and subjecting them to the standard FASP31 washes with 200 μl
of 8 M urea in 0.1 M Tris-HCl, pH 8.0 (UA buffer) by centrifugation (14,000 x g
for 20 min), 4 M Urea in 0.1 M Tris-HCl, pH 8.0 (UB buffer) by centrifugation
(14,000 x g for 20 min). Next, 50 μl of 4 M urea, 50 mM Tris-HCl, pH 7.9 was
added to the ﬁlters and this solution was diluted to a ﬁnal urea content of 1 M by
addition of 150 μl 50 mM Tris-HCl, pH 7.9. The mixture was incubated with 0.5 µg
of trypsin at 25 °C for 3 h. The RNA retained on the ﬁlter was collected by inverting
the ﬁlter and centrifugation at 14,000 x g for 20 min. After centrifugation, the
RNA in all the ﬁltrates and eluates was ethanol precipitated and analysed on a 1%
agarose gel.
Filters were also screened for retention of small nucleic acid oligos (36mer
ssDNA oligo, 21mer ssRNA oligo, 11mer ssRNA oligo, 6mer ssRNA oligo).
Recovery of the oligonucleotides in the ﬂowthrough was calculated by analysing
input and ﬂowthrough samples in a Nano-drop UV spectrometer.
Isolation of peptides in CAPRI. CAPRI combines on-bead digestion of
covalently linked RNA–protein complexes with RNA-FASP in order to subse-
quently purify adjacent peptides and UV crosslinked ribonucleotide-peptide
heteroconjugates.
In all, 4.4 × 108 crosslinked (UV or FA) S2 cells or eight 15 cm2 plates of UV
crosslinked HEK293 cells were resuspended in oligo-dT lysis buffer and
homogenised by using a rotor stator homogeniser. The extract was cleared by
spinning at 10,000 x g for 10 min and added to 4 ml suspension of oligo-dT
magnetic beads. The mixture was incubated at room temperature for 1 h rotating
at 10 rpm on a wheel. The beads were washed once with 40 ml OLB, once with
40 ml WB1 and twice with 40 ml WB2 at 4 °C. The beads were transferred to a
1.5 ml microcentrifuge tube and washed with 1 ml OBD buffer (50 mM Tris-Cl
pH 7.8, 200 mM LiCl, 1 mM EDTA). The on-bead digestion was performed at
25 °C for 3.5 h in 400 µl of OBD buffer (rotating at 4 rpm) by addition of 1 µg
Lys-C (Wako) per 40 µg of proteins. Next, the beads were separated (magnetic
stand) and the supernatant containing released peptides was removed. The
beads were transferred to a 5 ml protein low-binding tube and washed once
with WB2 and three times with WB3 both at 4 °C. The RNA-polypeptide
heteroconjugates were eluted from the beads in 400 μl of Elution buffer (10 mM
Tris-Cl, pH 7.5) by constant agitation (1100 rpm, thermomixer) at 56 °C for 4 min.
Eluted RNA-polypeptide heteroconjugates were adjusted to a ﬁnal
concentration of 2 mM EDTA, 50 mM NaCl, and 5 mM DTT. The samples were
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directly concentrated on 30 kD MWCO Microcon ultraﬁltration devices (Millipore,
forensic grade) by centrifugation at 16,000 x g for 30 min at 20 °C. In all subsequent
steps, solutions on the ﬁlter were ﬁrst mixed in a thermomixer at 600 rpm for 1 min
(RT). The ﬁlter units were ﬁrst washed once with 200 μl of 10 mM EDTA, 0.1 M
Tris-HCl, pH 7.5, and then with 200 μl of 8 M Urea in 0.1 M Tris-HCl, pH 7.9
by centrifugation (14,000 x g for 20 min). For cysteine alkylation 100 μl of 5 mM
Iodoacetamide (IAA) was added and the solution was incubated at 25 °C for 15 min
in the dark. IAA was washed away by centrifugation (14,000 x g for 20 min). This
was followed by a wash with 100 µl of UB buffer (50 mM Tris-HCl, pH 8.0, 4 M
urea). Lys-C (0.5 µg) was added to the ﬁlter in 100 µl UB buffer for another round
of digestion and incubated at 25 °C for 6 h for Drosophila S2 cells (10 h for HEK293
cells). After digestion the released peptides were washed away with a 100ul 0.5 M
NaCl wash. To estimate the efﬁciency of Lys-C digestion, these peptides were
cleaned-up using C18 STAGE tips71 and analysed by mass spectrometry. The
RNA-peptide heteroconjugates retained on the ﬁlter were further washed with 100
μl of 4 M Urea, 0.1 M Tris-HCl, pH 7.9. Next, 50 μl of 4 M urea, 50 mM Tris-HCl,
pH 7.9 was added to the ﬁlters and this solution was diluted to a ﬁnal urea content
of 1 M by addition of 150 μl 50 mM Tris-HCl, pH 7.9. The RNA-peptide
heteroconjugates were further digested overnight with 0.5 µg of trypsin at 25 °C.
Next day, the released adjacent tryptic peptides (liberated from site of RNA
crosslink) were collected by spinning (16,000 x g, 20 °C, 30 min). The ﬁlter units
were further washed with 100 μl of 1 M urea, 50 mM Tris-HCl, pH 7.9. Both
ﬁltrates were combined and labelled as pool A peptides. The RNA-peptide
complexes that have remained on the ﬁlter were again resuspended in 50 μl of 4 M
urea, 50 mM Tris-HCl, pH 7.9 buffer. The urea was diluted to 1M ﬁnal
concentration exactly as described above. To degrade RNA (and potential traces of
genomic DNA), 1 μl benzonase (25 U, Novagen) was added and the mixture was
incubated for 30 min at 37 °C. Subsequently an RNase cocktail consisting of 0.5 μl
RNases A (Thermo Scientiﬁc, 10 µg/μl), 1.0 μl RNase-T1 (Ambion, 1 μg/μl, 1 U/μl)
and 0.5 µl RNase I (Ambion, 100 U/µl) were added and incubated ﬁrst for 60 min
at 37 °C and second for 90 min at 52 °C with the aim of completely trimming the
remaining RNA-peptide heteroconjugates to a length of one to maximally three
ribonucleotides. Following a ﬁnal proteolytic digestion step (0.1 µg trypsin, 3 h at
37 °C) the released peptide-ribonucleotide heteroconjugates were collected (16,000
x g, 30 min at 20 °C). The ﬁlter units were washed for the last time with 50 µl 0.5 M
NaCl, 10 mM Tris-HCl, pH 7.4 and centrifuged as described above. Ultimately, the
ﬁltrates harbouring the ribonucleotide crosslinked peptides were combined and
labelled as pool B peptides. All peptide samples were acidiﬁed with formic acid
(0.1% ﬁnal concentration) prior to C18 STAGE tip column clean-up71. Both pools
(A and B) were analysed separately by LC/MS (described below). To identify
adjacent peptide the.raw ﬁles from pool A and B were processed together by
MaxQuant. To identify crosslinked peptides only the.raw ﬁles from pool B were
used. TFA was omitted from all steps throughout this protocol.
Isolation of FA-dom-peptides. FA crosslinked RBPs were puriﬁed from 4.4 × 106
S2 DRSC cells with oligo-dT beads as described before at 4 °C. Once the RNA had
been captured on beads, the proteins were digested. To pursue this the beads were
transferred to a 1.5 ml microcentrifuge tube and washed with 1 ml OBD buffer (50
mM Tris-Cl pH 7.8, 200 mM LiCl, 1 mM EDTA). The on-bead digestion was
performed at 25 °C for 1 h in 400 µl of OBD buffer (rotating at 4 rpm) by addition
of 1 µg Lys-C and 1 µg of trypsin. After 1 h the supernatant was removed and
replaced with 400 µl of OBD buffer for another round of digestion with 1 µg trypsin
for 2 h. Next, the beads were separated and the supernatant containing released
peptides was removed. The beads were transferred to a 5 ml protein low-binding
tube and washed once with 4 ml OLB, once with 4 ml WB2, three times with 4 ml
WB3 and ﬁnally with prechilled 1 ml 200 mM ammonium bicarbonate (ABC)
buffer for 2 min each. The RNA was eluted with 200 µl of 50 mM ABC buffer at 56
°C for 3 min and again with 100 µl of 50 mM ABC buffer at 56 °C for 3 min. The
eluates were cleared of remnant beads by using a magnet and spinning at 2000 x g
for 5 min. The RNA peptide bonds were de-crosslinked by incubating the eluates at
65 °C, 1100 rpm for 90 min. We took an aliquot of RNA for Bioanalyzer capillary
electrophoresis. The remaining RNA was degraded with a mixture of 0.5 µl of
benzonase, 0.5 µl of RNase A and 0.5 µl of RNase I for 90 mins at 37 °C at 1100 rpm
and for another 30 min at 52 °C at 1100 rpm. The peptides were further digested
with 0.5 µg trypsin and cleaned-up for liquid chromatography–mass spectrometry
(LC-MS) analysis by SP3 puriﬁcation72.
Peptide LC/MS analysis. General nanoLC-MS set-up was similar to one in Musa
et al.73. Brieﬂy, Q Exactive mass spectrometer (Thermo Fisher Scientiﬁc) interfaced
with an Easy nLC1000 UHPLC system (Thermo Fisher Scientiﬁc) was used for all
experiments. For chromatographic separation of peptides, peptides were analysed
on in-house packed fused-silica emitter microcolumns ((75 µm ID, 8 µm tip,
250 mm length; (SilicaTip PicoTips; New Objective) packed with 1.9 µm reverse-
phase ReproSil-Pur 120 C18-AQ beads (Dr. Maisch)). For RBPome samples,
peptides were separated by a 4 h linear gradient of 5–80% (80% ACN, 0.1%
formic acid) at a constant ﬂow rate of 300 nl/min. For RBD samples, CAPRI-
peptides were separated by a 1 h linear gradient of 5–80% (80% ACN, 0.1% formic
acid) at a constant ﬂow rate of 250 nl/min. For DDA acquisition, the “fast”
(RBPome) and “sensitive” (CAPRI-peptides) method from Kelstrup et al.74 was
adopted with the following alterations. The full scan was performed at 70,000
resolution (at m/z 200) with a scan window of 350–1650m/z. The automatic
gain control target for MS1 was set to 3e6 and for MS/MS scan it was set to 1e5. A
top10 workﬂow at a MS/MS resolution of either 17,500 or 35,000 (depending on
sample complexity) for selecting the most abundant precursor ions in positive
mode for HCD fragmentation (NCE= 28) was employed. Precursor ion charge
state screening was enabled, and all unassigned charge states, as well as singly
charged ions, were rejected. The lowest ﬁxed mass recorded in MS2 spectra was set
to m/z 100 ensuring the detection of all RNA derived marker ions in
ribonucleotide-peptide heteroconjugate spectra. Selected ions were excluded
from repeated fragmentation in a time frame of 30 s (CAPRI-peptides) or 60 s
(RBPome samples).
MaxQuant analysis. DDA MS raw ﬁles for RBPome, CAPRI adjacent peptides
and FA-dom-peptides were analysed by MaxQuant32 software (version 1.5.2.8) and
peak lists were searched either against the Drosophila or human Uniprot FASTA
database (version September 2015) concatenated with a common contaminants
database by the Andromeda search engine embedded in MaxQuant. Cysteine
carbamidomethylation was set as a ﬁxed modiﬁcation and N-terminal acetylation,
deamidation (NQ) and methionine oxidation as variable modiﬁcations. FDR
was set to 1% for proteins and peptides, respectively and was determined by
searching a reverse database. Enzyme speciﬁcity was set to trypsin (enabling
cleavage N-terminal to proline), and a maximum of two (RBPome) or three
(CAPRI) missed cleavages were allowed in the database search. For deciphering
Lys-C missed cleavage four missed cleavages were allowed and enzyme speciﬁcity
was restricted to Lys-C. Peptide identiﬁcation was performed with an allowed
initial precursor mass deviation up to 4.5 ppm and an allowed fragment mass
deviation of 25 ppm with a minimum required peptide length of 6 amino acids
and a maximum peptide mass and charge of 4600 Da and 7+ , respectively. The
“match between runs” (matching time window 0.7 min), and “second peptide”
features were enabled. Label-free quantiﬁcation was done using the maxLFQ
algorithm. Protein groups were identiﬁed with at least two peptides, wherein one of
them should be unique to this protein group.
UV-RBPome and FA-RBPome data analysis. The MaxQuant proteinGroups.txt
output ﬁle was used to identify UV and FA RBPomes. Contaminant protein groups
were removed. Missing raw intensity values were imputed with minimum intensity
observed. Protein groups deﬁned by the presence of more than two unique peptides
were statistically analysed by a moderated two-sided t-test from the Limma
package (FDR < 0.01) comparing crosslinked to the respective non-crosslinked
samples and subsequently ﬁltered by an average intensity cutoff ( > eightfold). A
ﬁnalised unique list of genes was selected from the ﬁrst protein of the majority
protein ID column in MaxQuant output tables.
Analysis of ADJ-peptides. We used the peptides.txt output ﬁles from MaxQuant
analysis to catalogue tryptic adjacent peptides that are signiﬁcantly enriched in
UV crosslinked samples. Peptides mapping to contaminants were removed.
Missing intensity values were imputed with the minimum peptide intensity
observed. Peptides were selected based on a moderated t-test (Benjamini–Hochberg
FDR < 0.05) comparing crosslinked to the respective non-crosslinked samples
and subsequently ﬁltered by an average intensity cutoff ( > eightfold). Peptides
mapping multiple times to the very same protein sequence (UniProt ID) were
removed. An in-house python script was developed to assemble a database of
adjacent peptides, uniprot sequences and Pfam domain identiﬁcations. The tryptic
adjacent peptides were extended in silico to the next nearest (theoretical) Lys-C
cleavage site (lysine) in both directions (N- and C-terminal extension) and were
named ADJ-peptides. Finally, the longest protein isoform possessing the largest
total number of mapped ADJ-peptides was chosen to represent each gene based on
Ensembl gene ID. This protein list constitutes the ADJ-RBPome. Peptide coverage
was calculated for each amino acid position in the protein sequence based on the
number of tryptic adjacent peptides identiﬁed at the position. Comparison between
full-protein peptides and ADJ-peptides was performed by treating the MaxQuant
peptides.txt output ﬁle from interactome capture similar to the tryptic adjacent
peptides.
Domain peptides from published studies were taken from their respective
reports and integrated into the CAPRI database. Analysis of RBDpep (equivalent
of adjacent peptide in CAPRI protocol)21,52 and pCLAPMS (ref.40) peptides was
performed similar to adjacent peptides to yield extended-RBDpeptides and
extended-pCALP peptides (equivalent to ADJ-peptides). The RBDpeptides were
extended to the next Arg-C or Lys-C digestion sites based on the enzyme used
in domain enrichment. RBR-ID[22] peptides were mapped to the given proteins
without any in silico extension.
Analysis of XL-peptides. In previous studies, the crosslinked peptides were
analysed using specialised database-based searches18,19,75,76 (for a brief summary
see Supplementary Note 4). In CAPRI, we employ a benchmarked commercial
software (PEAKS Studio, BSI, Canada) that is easy to use and that combines
computational peptide de novo sequencing (to derive peptide sequence tags: PSTs)
with conventional database searching36,37. Two decades ago, pioneering work by
Mann and Wilm77 suggested that PST assisted database searching is both error
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tolerant and enables the identiﬁcation of peptide sequences bearing unknown
PTMs. Hence, instead of heuristic ﬁltering applied prior to bioinformatic data
analysis (RNPXL) the concept of PSTs is harnessed to select interpretable
MS2 spectra (exhibiting good partial peptide-spectrum matches: PSMs) from
the complete raw dataset in order to reduce the search space for identifying the
ribonucleotide adduct. Brieﬂy, PEAKS identiﬁcation of peptides is made of three
steps: De novo spectrum analysis, database search (PEAKS-DB) and PTM search
(PEAKS-PTM). The identiﬁcation of PTMs is achieved by integrating the database
searching with the initial de novo sequencing analysis (PST generation). Impor-
tantly, its algorithm maximises PTM identiﬁcation with the possibility to make
multiple custom modiﬁcations. The PEAKS de-novo algorithm is supposed to be
more tolerant towards gaps because it does not use the graph theory model for
PSM analysis but tries to select the best possible sequence of amino acids using
local probabilities of amino acid identity. The database peptide mapping can take
place with multiple PSTs predicted from the same MS2 spectrum. This allows
complex PTMs to be matched in a spectrum78. For more detailed information a
description of RNA adduct annotation is outlined below.
The HCD/CID fragmentation of crosslinked peptides preferentially cleaves
the glycosidic and phosphodiester bonds but not the covalent link between the
base and the amino acid side chain (Supplementary Fig. 7a). Thus, the
ribonucleotide (A, G, C, U) crosslink reacts in the gas phase of the mass
spectrometer as a single PTM composed of two parts: the ribonucleotide base
(A’, G’, C’, U’) and the rest of the ribonucleotide (ribose+ phosphate (PO4)).
Importantly, this rest can fall off as a neutral loss during HCD/CID fragmentation.
This behaviour (fractional PTM neutral loss) is different compared to classical
PTM neutral losses (e.g., phosphoric acid loss for serine/threonine
phosphorylation, carbohydrate loss for serine/threonine O-glycosylation) because
in the latter cases the entire molecule that deﬁnes the PTM gets dissociated during
HCD/CID.
In the PEAKS software version 8.0, it is not possible to deﬁne a custom
PTM annotation, which would provide fractional neutral loss annotation of a
particular PTM. To account for this, we formally split each of the ribonucleotide
into two PTM sets; the nucleobase (A’, G’, C’, U’) and the rest of the nucleotide
(ribose+ PO4). With these PTM deﬁnitions, peptides containing a single
nucleotide (ribo-mononucleotide) crosslink will be annotated by PEAKS to contain
one of the bases (e.g., U’) at the site of modiﬁcation (amino acid residue) and “rest”
(the part of the PTM that dissociates during HCD/CID) annotated at one of the
peptide termini. We also included an additional PTM of “cyclic-rest” to account
for the possibility of cyclised ribose sugar phosphate left behind as a by-product
of RNA degradation by RNase enzymes (deﬁnitions of RNA-PTMs in
Supplementary Data 4).
For ribo-dinucleotides we simply deﬁne two sets again as a combination of
crosslinked base (A’, G’, C’, U’) and the remaining modiﬁcation as the sum of a
ribo-mononucleotide and “rest” (ribose+ phosphate) to end up with a complete
(standard) neutral loss (of a PTM), instead of fractional neutral losses. For
example, if there are two nucleotides UA crosslinked to a peptide via U, we
expect the peptide to be annotated by two modiﬁcations (A+ rest) and U’ base.
The U’ base modiﬁcation would be shown by PEAKS at the site of crosslinking
(amino acid residue) and A+ rest (that again dissociates upon HCD/CID)
would again be formally annotated at the N- or the C-terminus of the peptide.
In the same way, the ribo-trinucleotides were deﬁned as a combination of
crosslinked base and the remaining modiﬁcation as a sum of the ribo-dinucleotide
and “rest”.
The raw data were searched with PEAKS 8.0. The PEAKS peptide identiﬁcation
is performed in three steps: de novo peptide analysis (PST generation), database
search, and PTM analysis. In total, we allow 34 RNA (ribonucleotide adduct)
speciﬁc PTM modiﬁcations. We chose three methods (Search Strategies—SS1,
SS2 and SS3) (Supplementary Fig. 7b) to check for the speed of analysis of
XL-peptides.
For all search strategies, and PEAKS algorithms (PEAKS de-novo, PEAKS-DB
and PEAKS-PTM), the MMD for monoisotopic precursor and fragment ions was
set to 10 ppm and 0.02 Da (Q Exactive data), respectively. The PEAKS search
considered cysteine carbamidomethylation as a ﬁxed modiﬁcation and
deamidation (N and Q), methionine oxidation, as well as protein N-terminal
acetylation as variable post translational modiﬁcations (PTMs or Standard
modiﬁcations) (Supplementary Fig. 7b). Enzyme speciﬁcity was set to trypsin
and non-speciﬁc cleavage was disabled. The results were limited to peptide
spectrum matches harbouring a maximum of two missed cleavages and three
variable PTMs per peptide. Finally, the peptides were selected with a FDR cutoff
set at 5%.
In the ﬁrst iteration (SS1) the RNA-PTMs were used only in the last step of
the PEAKS workﬂow (PEAKS-PTM search). This approach was fastest as none
of the RNA PTMs are considered for de novo analysis. In SS2 we merely used
the stably bound base modiﬁcations (A’, G’, C’ U’) for de novo and PEAKS-DB
analysis and all 34 modiﬁcations were utilised at the PTM matching stage.
SS3 is the computationally most demanding approach by accounting for all
possible RNA modiﬁcations at each step of the PEAKS workﬂow (PEAKS de-novo,
PEAKS-DB and PEAKS-PTM). The number of unique peptides and spectra
identiﬁed by each of the search strategies is summarised for Drosophila XL-
peptides data in Supplementary Data 4. The peptides identiﬁed in each of the
search strategies were screened for those containing RNA-PTMs. Further, the
RNA-PTM combinations on each peptide were screened by a custom python
script to select only those PTMs, which were composed of a single-nucleobase
or complete single/di/trinucleotides (Supplementary Fig. 7c). Combinations of
PTMs that represent biochemically impossible combinations (like “rest” only or
“rest+A” and “rest+U”) were removed. Subsequently, each of the above
searches were also manually curated to remove low-quality spectra that might
lead to identiﬁcation of false positives. This removal was based on low spectral
scores and incomplete spectral annotation. SS1 was the fastest strategy, however
SS3 strategy identiﬁed the most spectra. Hence, we chose SS3 strategy for
XL-peptide analysis.
In case of Drosophila, six biological replicates were utilised for crosslinked
peptide analysis, whereas for human samples three biological replicates were
considered. Search strategy 3 was employed for the ﬁnal crosslinked peptide
analysis and a peptide FDR cutoff of 5% was applied. A custom python script was
used to map only the crosslinked peptides to annotated protein sequences. The
spectra of peptides mapping known PDB structures were manually annotated to
visualise the amino acid in proximity to RNA (Supplementary Data 6). Spectra
of many peptides mapping to novel domains and IDRs were also manually
annotated (Supplementary Data 7). Poorly characterised spectra identifying novel
domains were removed.
In the manual veriﬁcation, the ﬁrst step of quality check is the coverage of
amino acids annotated in the spectrum. The second step is conﬁrmation of the
proposed RNA-PTM combination. The chosen spectra can then be annotated.
For example, in Supplementary Fig. 7f we show ﬁrst a schematic and below it an
example of tryptic peptide-crosslink harbouring a single ribo-mononucleotide
adduct. The higher m/z range region contains the neutral loss area that is made up
by molecular ions, which have lost a phosphate group, a ribose group or both
(the ribose+ phosphate moiety) from the peptide-ribonucleotide conjugate. In case
of a crosslinked ribo-mononucleotide, this should result in the sequential loss of
phosphate and ribose, respectively (Supplementary Fig. 7f). In general, no marker
ions arising from the protonated RNA base are observed as the base remains
covalently attached to the amino acid.
In the case of a crosslinked ribo-dinucleotide, we can observe neutral loss peaks
derived by the loss of phosphate, ribose and the entire second ribo-mononucleotide
moiety (that is not directly covalently bound to the amino acid residue). More
importantly, singly charged (protonated) RNA nucleotides and bases can now also
be detected in the lower m/z range of the spectrum (also called marker ions). We
observed protonated ions of the nucleobases of A’ (136), G’ (152), C’ (112) and U’
(113). This feature is somehow analogous to the immonium ions observed in the
lower m/z range for certain protonated amino acids (e.g., tyrosine, tryptophan
immonium ions). The signals for nucleobase marker ions are in general the
strongest in the spectrum of a peptide crosslinked to a ribo-dinucleotide (hence
called the base peak of the spectrum). The marker ion for the adenine base
(m/z 136) conﬂicts with the immonium ion for tyrosine, but the relative intensity is
different. Owing to lower gas phase stability of ribo-dinucleotide adducts during
CID/HCD, RNA marker ions will often constitute the base peak of the spectrum.
Protonated mono-nucleotides from A (330/312 a.m.u) and C (306 a.m.u.) and U
(307 a.m.u.) (Supplementary Data 5–7 and Fig. 4c) are frequently observed.
In the case of the rarely observed ribo-trinucleotide-peptide heteroconjugates
(when using CAPRI), peaks similar to dinucleotide crosslinks are detected,
however, it becomes more complicated to annotate the neutral loss region.
Advantages of using PEAKS software for crosslinked peptide identiﬁcation are
as follows: (i) No preﬁltering of peak lists is required. (ii) The interactive
environment of PEAKS enables easy visualisation of each of the unique crosslinks
(Supplementary Fig. 7d). (iii) Annotation of the amino acid involved in the
crosslink in a majority of spectra. (iv) Identiﬁcation of peptides containing
nucleobases only.
Union of ADJ- and XL-peptides into CAPRI-peptides. ADJ and XL-peptides
tables were simply appended without merging overlapping peptides in order to
maintain their distinct information. Custom Python and sqlite3 scripts were used
to combine information about peptide coverage and domain information to
summarise domain identiﬁcation and plot protein coverage images.
Analysis of FA-dom-peptides. We used the peptides.txt output ﬁles from Max-
Quant analysis to to identify the peptides enriched in FA crosslinked samples. First,
peptides mapping to contaminants were removed and missing intensity values
were imputed with the minimum peptide intensity observed. The peptides were
selected based on a moderated t-test (Benjamini–Hochberg FDR < 0.15) comparing
crosslinked to the respective non-crosslinked samples. In spite of a higher FDR
cutoff the selected peptides were observed in at least two FA crosslinked replicates.
The peptides were subsequently ﬁltered by an average intensity cutoff ( > eightfold).
An in-house python script was developed to analyse the overlaps of the FA-dom-
peptides with Pfam domain identiﬁcations and disordered regions.
GO term enrichment analysis. The Gene ontology, InterPro domain and KEGG
pathway enrichment analysis for Drosophila and human proteins was performed
by DAVID on-line tool79 using all the protein-coding genes as background and
Benjamini–Hochberg correction (5% FDR) for multiple testing. The KEGG
pathways were visualised via the DAVID tool and KEGG mapper tool80.
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Analysis of RNA protein complexes based on proximity to RNA. Drosophila
protein complex information was extracted from the Compleat tool81 FA-RBPome,
UV-RBPome, ADJ-RBPome to XL-RBPome. A .sif ﬁle was generated with RNA as
a new molecule interacting with each of the members in the complex with above
scores used as the weight of interaction. This new complex network was visualised
in Cytoscape 3.0 after applying force-directed layout based on the weight of
interaction.
Analysis of novel domains and orthologs. The protein sequences were annotated
using Pfam domains (release Jan 2016). Pfam deﬁnitions from InterPro
database were used for deﬁning the extent of domains in UniProt sequences. A list
of classical RBDs was constructed by combining information described in the
following. (1) Literature information11, (2) a compiled list of domains possessing
the keyword “ribosom”, (3) those domains classiﬁed as “RNA binding” in their
GO annotations and (4) a small manually curated list based on literature. CAPRI-
peptides mapping outside this deﬁned list of RBDs were classiﬁed to identify
novel RBDs. Disordered regions were extracted from MobiDb82 (by personal
communication). DOIPT tool83 was employed to obtain pairs of orthologs by
mapping all Drosophila protein-coding genes to human genes by excluding low
score hits (score > 1, unless only match score is 1). As a conservative measure,
we utilised only those ADJ-peptides, which mapped to unique genes for ortholog
analysis.
Amino acid composition analysis. Comparison of amino acid composition
between two groups of sequences were tested by Fisher’s exact test and the p-values
were corrected for multiple hypothesis testing by Benjamini–Hochberg correc-
tion21. Comparison of amino acid composition for RNA conjugated amino acids
was performed by simply calculating the amino acid percentage composition.
Amino acid composition analysis for yps/YBX1 CAPRI-peptides was conducted by
using the Composition Proﬁler online tool84 considering the complete (Swiss-Prot
and TrEMBL) UniProt Knowledgebase as background and using a Bonferroni
correction for multiple testing.
Motif discovery. In order to avoid the bias which may result from a repeated
overlap between XL-peptide and ADJ-peptides sequences, only ADJ-peptides were
used for motif discovery. DREME (Discriminative Regular Expression Motif Eli-
citation) was used to discover short, ungapped motifs that are relatively enriched in
the fraction of ADJ-peptides, which are exclusively mapping to disordered domains
choosing all the UV-RBPome complete protein peptides (FP-peptides) as back-
ground. MEME (Multiple Em for Motif Elicitation) was performed on both unique
human and Drosophila ADJ-peptides pooled together allowing a maximum motif
length of 16 and a maximum of 50 sites per motif. The returned motif sequences
and motif sites were screened to identify the Drosophila and/or human proteins
(UniProt IDs) harbouring these motifs. MEME and DREME analysis was carried
out using a local installation of the MEME suite57.
Evolutionary analysis of conserved of IDRs. Ortholog pairs of proteins scaled to
same length were visually compared. CAPRI-peptide positions were evaluated
based on their relative position in respect to the protein N- and C-termini, as well
as their relative distance towards other globular domains present in these proteins.
Multiple sequence alignments generated in Clustal Omega/MAFFT were visualised
in Jalview. A user deﬁned colouring scheme was utilised to highlight R/G
amino acids.
Protein interactome of large RNA. We have developed a large RNA (RNA length
> 200 nucleotides) interactome capture protocol, which shares similarities to
recently published 2C protocol47. The procedure uses silica-based puriﬁcation
of large RNA (RNA longer than 200 nucleotides). For large-scale experiments
(25 million HEK293 cells equivalent to one 15 cm2 plate) the same procedure was
performed using (RNAeasy Midi kit Cat No. 75144) with some modiﬁcations. For
the large-scale interactome capture 25 million UV crosslinked (254 nm, 200 mJ/
cm2) and non-crosslinked HEK293 cells (a 15 cm conﬂuent plate) were resus-
pended in 3.5 ml RLTplus Buffer (Qiagen Cat No. 1053393, probably contains ~5
M guanidine thiocyanate and proprietary detergents) with 35 µl of 14.3 M beta
mercaptoethanol. The samples were homogenised with a rotor stator homogeniser
at 2000 rpm for 30 s. The lysate was loaded on the midi genomic DNA elimination
column (Enzymax EZC222) and spun through at 3000 x g for 5 min. An equal
volume of 70% ethanol was added to the ﬂowthrough and loaded onto a midi RNA
column (RNAeasy Midi kit Cat No. 75144). The ﬂowthrough was collected after
centrifugation at 3000 x g, 3 min and stored at RT for a second iteration of RNA
isolation. The column was washed once with 3.5 ml of RW1 wash buffer (Pro-
prietary composition: contains guanidine salts) and twice with 2.5 ml RPE wash
buffer from RNAeasy Midi kit with centrifugation at 3000 x g, 3 min. The columns
were later dried by additional centrifugation at 3000 x g 2 min. The RNA along with
the UV crosslinked RNA-protein complexes were eluted by adding 500 µl of pre-
heated (75 °C) nuclease-free water to the columns and incubating for 1 min at
room temperature. The eluate was collected as ﬂowthrough after centrifugation at
3000 x g for 3 min. The column was reused to isolate RNA from the ﬂowthrough
fraction (kept aside beforehand). The eluted RNA and protein content was
quantiﬁed by using Qubit ﬂuorometric quantiﬁcation. RNA was also quality
controlled by Bioanalyzer pico chip CE. For protein analysis, RNA was degraded by
addition of 1/10th volume of 10x RNA digestion buffer (100 mM Tris-HCl pH 7.5,
1.5 M NaCl, 0.5% NP-40) and 1 µl of a cocktail of RNase A and benzonase (1 μl
benzonase, 25 U, Novagen+ 1 μl RNases A, Thermo Scientiﬁc, 10 µg/μl+ 300 µl of
1x digestion buffer) and incubated at 37 °C for 12 h. Proteins were subsequently
visualised by both silver staining and western blot analysis. For small scale capture
experiments (1–10 million cells) the above procedure can be performed employing
Qiagen AllPrep DNA/RNA mini kit 80204.
Antibodies. We utilised the following primary antibodies directed against
Drosophila Mle (in-house), glorund (DSHB 5B7_C), Squid (DSHB 2G9-c),
Rump (DSHB 5G4), Histone H3 (Active Motif 39763) and Beta Actin (Santa
Cruz (I-19) sc-1616) as well as antibodies recognising human DHX9 (Abcam
ab183731), HNRNPM1–4 (Santa Cruz sc-20002), EIF-4A1 (Abcam EPR14506/
Ab185946), KHDRBS1 (Sigma S9575), BETA ACTIN (Santa Cruz (I-19) sc-1616),
histone H3 (Active Motif 39763), histone H4 (Millipore 05–858), OXPHOS
Rodent WB Antibody Cocktail (Abcam ab110413- to detect Complex I member
NDUF88, Complex II member SDHB, Complex III member UQCRC2,
Complex IV member MTCO1 and Complex V member ATP5A1), OXPHOS
complex II member SDHA (Invitrogen 459200), TOMM20 (Santa Cruz sc-11415),
XRCC5 (Invitrogen MA5–15873), MSH6 (Cell Signalling 5424P), GAPDH
(Bethyl A300-641A), HUR (3A2) (Santa Cruz 5261) and FLAG HRP (Sigma
A8592). All antibodies were used at a dilution of 1:1000 in 5% fat free milk
powder dissolved in 0.3% Tween-20 phosphate buffered saline (Supplementary
Figs 19–21).
PNK assay. Respective proteins and domains were cloned into pcDNA5-FRT-TO
plasmids with addition of a C-terminal 15 kD 3Flag-HBH tag comprising a
sequential arrangement of the following epitope-tag sequences: Flag, hexahistidine,
in-vivo biotinylation signal peptide, hexahistidine that are derived from the
HBH tag85. Afﬁnity puriﬁcation of the tagged proteins was adopted from a
protocol described in Maticzka et al.48. Proteins in Fig. 6 (SRRT, MSN, EZR, RDX,
PEBP1, SAP18, CSNK1D, ACADSB, ALDH6A1, MCAT, RACK1, PPIE) were
stably integrated into a single FRT site Flp-In™ T-REx™-293 Cell Line using
the product protocol. The proteins were expressed by inducing with 0.1 µg/ml
doxycycline. For the rest of the proteins and domains the HEK293 cells were
transiently transfected, induced with 0.1 µg/ml doxycycline and harvested in
Lysis buffer (1% Triton-X, 0.1% Tween-20, 1x PBS, 0.3 M NaCl, 1x Complete
protease inhibitors). The lysate was sonicated for 5 min (Bioruptor sonicator,
Hi setting, 30 s ON and 30 s OFF) and further cleared by ultracentrifugation at
20,000xg for 15 min. The afﬁnity puriﬁcation of the tagged proteins was performed
in two steps by ﬁrst using TALON-Dynabeads (for His tag puriﬁcation) followed
by MyOneC1 Streptavidin Dynabeads (for Biotin tag puriﬁcation). TALON bead
puriﬁcation starts by incubating them with extracts for 10 min at 4 °C. The beads
are washed twice with Lysis buffer and proteins are eluted by using 250 mM
imidazole in Lysis buffer. Subsequently, the eluates were incubated with MyOneC1
beads for 30 min and washed sequentially with iCLIP lysis buffer (50 mM Tris-HCl,
pH 7.4, 140 mM NaCl, 1% Triton-X, 0.1% SDS, 0.1% DOC, 1 mM EDTA),
Denaturing lysis buffer (20 mM Tris-HCl, pH 7.4, 0.5 M LiCl, 1% SDS, 1 mM
EDTA), High-salt buffer (HSB) (50 mM Tris-HCl, pH 7.4, 1 M NaCl, 1% Triton-X,
0.1% SDS, 0.5% DOC, 1 mM EDTA) and NDB (50 mM Tris-HCl, pH 7.4, 0.1 M
NaCl, 0.1% Tween-20). The beads were resuspended in NDB buffer and treated
with 2 µl Turbo DNase I and 10 µl 1:1000 diluted RNase I for 3 min at 37 °C in a
thermomixer at 1100 rpm. Next, the beads were washed twice with NDB buffer
again. 10% of beads were separated and processed further without radioactive
labelling in order to detect proteins by western blot. The crosslinked RNA on the
remaining beads was radiolabeled with 0.5 µl of 10 µCi/µl gamma-[32P]-ATP using
T4 Polynucleotide Kinase in 20 µl PNK buffer (20 mM Tris-HCl, pH 7.4, 10 mM
MgCl2, 0.2% Tween-20) for 10 min at 37 °C in a thermomixer set at 900 rpm. The
beads were washed twice with NDB buffer and proteins from both radiolabeled and
non-labelled tudes were eluted in 1x NuPAGE LDS sample buffer at 90 °C for 5
min in a thermomixer at 1100 rpm. The unlabelled and unlabelled proteins were
separated on a SDS gel and transferred separately to nitrocellulose membranes. The
proteins were detected by using an anti-Flag-HRP antibody (1:1000 dilution)
(Sigma A8592) and the labelled RNA-protein heteroconjugates were visualised by
autoradiography.
DNA oligos used. Oligos used to clone protein domains:
LARP1(DM15 domain)
For primer: 5ʹ AGACTTAATTAAGCCACCATGCGTACTGCTTCCATC
AGCTCCAG
Rev primer: 5ʹ AATAGGCGCGCCTTTGGGGTCAATGTCCAAATTTT
UBAP2L (IDR - RG rich)
For primer: 5ʹ AGACTTAATTAAGCCACCATGGATGGTGGCCAGACG
GAATC
Rev primer: 5ʹ AATAGGCGCGCCCTGGGAGCCTGTAGTACTGCCG
HNRNPU (SPRY-AAA domains)
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For primer: 5ʹ AGACTTAATTAAGCCACCATGGCCAAATCTCCTCAG
CCACCTG
Rev primer: 5ʹ AATAGGCGCGCCTTTTTGGGCTTCTTCCTTCTGAAGTT
ILF3 (DZF domain)
For primer: 5ʹ AGACTTAATTAAGCCACCATGATTTTTGTGAATGA
TGACCGCCAT
Rev primer: 5ʹ AATAGGCGCGCCCCCGTCCTCCTCCATTGGG
GTPBP4 (GTP-binding domain)
For primer: 5ʹ AGACTTAATTAAGCCACCATGAGAAAAGTCAAATTTAC
TCAACAGAATTACC
Rev primer: 5ʹ AATAGGCGCGCCAACTTTAATAACACCTTCCTCAG
TCAGG
YLPM1 (IDR)
For primer: 5ʹ AGACTTAATTAAGCCACCATGAGAGGCAACAGCTCA
TCTTACAGAG
Rev primer: 5ʹ AATAGGCGCGCCTCCTCTTTCTGGATACTCTCGAATC
PRRC2A (IDR)
For primer: 5ʹ AGACTTAATTAAGCCACCATGATAACCAAGGGGAAG
CTAGGGG
Rev primer: 5ʹ AATAGGCGCGCCTTTATCCTGCTGCTGAGCCCTCC
UBAP2L and proteins in Fig. 4e were subcloned from the human ORFeome
V5.1 collection (Open Biosystems).
qPCR oligos for detection of genomic DNA contamination
Drosophila roX2
For primer: 5' AGCTCGGATGGCCATCGA
Rev primer: 5' CGTTACTCTTGCTTGATTTTGC
Drosophila rpl22
For primer: 5' GGCTAGCCCGAAGTTTTCTT
Rev primer: 5' AGCTGATCCCTTCAGTGGAA
Drosophila hxk
For primer: 5' AGTGTGTACCGCTTCCATCC
Rev primer: 5' ATCAGATCGAAGGTGATGCC
Drosophila 18s rRNA
For primer: 5' CTGAGAAACGGCTACCACATC
Rev primer: 5' ACCAGACTTGCCCTCCAAT
Drosophila tubulin
For primer: 5' TGTCGCGTGTGAAACACTTC
Rev primer: 5' AGCAGGCGTTTCCAATCTG
Drosophila actin
For primer: 5' GCGTCGGTCAATTCAATCTT
Rev primer: 5' AAGCTGCAACCTCTTCGTCA
Drosophila Rpl32
For primer: 5' ATGCTAAGCTGTCGCACAAATG
Rev primer: 5' GTTCGATCCGTAACCGATGT
Human 18s rRNA
For primer: 5' CTCAACACGGGAAACCTCAC
Rev primer: 5' CGCTCCACCAACTAAGAACG
Human POLG
For primer: 5' ATCATAGTCGGGGTGCCTGA
Rev primer: 5' ATCATAGTCGGGGTGCCTGA
Human GAPDH
For primer: 5' TAGGGCCCGGCTACTAGCGGT
Rev primer: 5' CGCCAGGCTCAGCCAGTCCC
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The proteomics raw data and MaxQuant analysis output have been deposited to the
ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the
PRIDE partner repository with the dataset identiﬁer PXD013338. Additional
experimental data including all PEAKS software analysis, MaxQuant outputs, all protein
proﬁle images and motif analysis are available at https://owncloud.gwdg.de/index.php/s/
aZcFjXXtbQG0wjQ/authenticate; Password: Capri$2018. In source data ﬁle we have also
included the source data for nucleic acid analysis in Supplementary Figs 1d, f, g, 5d, 6e. A
reporting summary for this Article is available as a Supplementary Information ﬁle. All
other data supporting the ﬁndings of this study are available from the corresponding
authors upon reasonable request.
Code availability
All custom code is available at https://owncloud.gwdg.de/index.php/s/
aZcFjXXtbQG0wjQ/authenticate; Password: Capri$2018.
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